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6ABSTRACT
Abstract
Humans are exposed to genotoxic carcinogens, such as polyaromatic hydrocarbons
(PAHs), in their everyday lives. The human body has efficient means to deal with
the adsorbed harmful compounds. However, wide inter-individual difference has
been shown to exist in the capacity to resist the ill effects caused by environmental
insults. These variations are therefore suggested as important modifiers of individu-
al responses to chemical carcinogens. Many xenobiotic metabolizing enzymes and
DNA repair proteins exhibit genetically determined polymorphism in their activities
and expression. The aim of this thesis was to study the influence of polymorphisms
in DNA repair genes XRCC1, XRCC2, XRCC3, XPC, XPD, and XPG on DNA damage
(single-strand breaks [SSBs]), cytogenetic damage (mutagen sensitivity, chromosomal
abberrations [CAs], and sister chromatid exchanges), and the risk of cancer in the
upper aerodigestive tract (UAT). The XRCC1 codon 280 variant allele was associat-
ed with elevated number of chromosome breaks induced by bleomycin in vitro
(mutagen sensitivity), and with a higher frequency of chromosome breaks in pe-
ripheral blood lymphocytes of individuals with low exposure levels. Carriers of XRCC1
codon 399 variant allele displayed a higher frequency of chromatid breaks and SSBs,
and a diminished irradiation-specific repair activity. The XPD codon 23 variant al-
lele was associated with a decreased capacity to repair gamma-irradiation-induced
DNA strand breaks in smokers, and with elevated levels of chromatid-type aberra-
tions. The XPC exon 15 wild type allele was associated with a lower level of SSBs,
abasic sites and 8-oxoguanosines. Carriers of XPG exon 23 variant allele exhibited
higher levels of SSBs. The XRCC2 variant allele and the XRCC3 wild type allele were
associated with the elevated risk of UAT cancers in smokers. These findings sub-
stantiate the earlier studies where phenotypic effects were discovered for DNA re-
pair gene polymorphisms. In conclusion, the present results show that polymor-
phisms of DNA repair genes are able to influence individual responses to genotoxic
and carcinogenic exposures. This should facilitate a better characterization of risks
and eventually enable the protection of people most vulnerable to adverse effects.
Methodological improvements may also be indicated, if the DNA repair gene gen-
otypes are taken into account when using cytogenetic methods for human biomon-
itoring and cancer risk assessment.
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I Review of the literature
1. Introduction
All humans are exposed to various natural and artificial sources of potentially harm-
ful compounds and radiation. People are also frequently exposed to chemicals in
their working environment (factory workers, cleaning technicians, etc.), and every-
day life (smoking, drinking alcohol), and hobbies (gardening, construction work,
etc.). For people living in cities and other municipalities, a large portion of the expo-
sure comes from atmospheric particles, radon, and UV-light. Exposures to genotox-
ic compounds can induce mutations. Even a low exposure of cancer initiating chem-
icals, such as polyaromatic hydrocarbons (PAHs), if prolonged, may lead to accu-
mulation of mutations in the somatic and germ cells and, eventually, to develop-
ment of tumors and cancer (Amdur et al., 1991).
Genotoxic carcinogens affect the genome. Genetic factors are thought to play a
central role in determining individual susceptibility to genotoxins; similar exposure
will result in different genotoxic response in different individuals. The factors re-
sponsible for difference between individuals include genetic polymorphisms of
enzymes functioning in the metabolism of xenobiotics (substances foreign to the
organism) and DNA repair.
After initial adsorption into the body, most xenobiotics go through a two-phase
metabolism. Because well-adsorbed xenobiotics are usually not very soluble in water,
they have to be converted into a water-soluble form to make them more excretable.
This is the so-called metabolic activation step (Phase I), where hydroxyl groups are
added to the xenobiotics (catalyzed by cytochrome P450 oxidases and haemoglo-
bin). The resulting compounds are often more reactive than their parent compounds.
The next step is called the inactivation or detoxification phase (Phase II), where the
reactive compounds are conjugated with innate molecules, for example, glutathione
conjugation is catalyzed by glutathione S-transferases (GSTs) and acetylation is
mediated by N-acetyltransferases (NATs). In the process, the reactivity of the com-
pound is diminished and it is flagged to excretion. However, during the process,
some of the products can react with DNA in the cells, and produce potentially lethal
DNA lesions, strand breaks, and adducts.
Cellular DNA damage can be repaired. In fact, cells have very powerful repair
mechanisms readily at their disposal; DNA strand breaks can be sealed by homolo-
gous or non-homologous methods, so that transcription and DNA replication can
continue seamlessly. DNA adducts can be cleaved from the DNA either in short (base
excision repair [BER]) or long patches (nucleotide excision repair [NER]). If these
measures fail, the cell can go to apoptosis to preserve the parent organism. (Amdur
10
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et al., 1991) Because both the xenobiotic metabolism and DNA repair may affect the
level of genotoxic damage in cells, both should be considered when genotoxic ef-
fects are assessed in humans.
To date, several biological markers of exposure, effects, and susceptibility have
been developed. For biological monitoring of exposure, peripheral blood or other
tissues, such as adipose tissue, can directly be sampled, or the excretion of metabol-
ic products of adsorbed xenobiotics can be quantified from urine or faeces. Many
genotoxic chemicals bind to DNA and form DNA-adducts, whose amount can be
quantified. Cytogenetic biomarkers, e.g., chromosomal aberrations (CAs), sister chro-
matid exchanges (SCEs), and micronuclei (MNs), can be detected from peripheral
blood leukocytes. Their frequency is a suitable marker for genotoxic exposure and
effects. Such biological markers are considered superior to chemical markers, since
they reflect the biologically relevant dose (Amdur et al., 1991). In addition, the rela-
tion of certain enzymatic polymorphisms and cancer can be studied in an epidemi-
ological framework.
A schematic presentation of the metabolic and DNA repair pathways leading to
various outcomes (outlined above) is presented in Figure I.
In this thesis, data about individual DNA repair capacity are presented on three dif-
ferent reductionistic levels (cell, individual and population):
1. The effect of polymorphic DNA repair genes on the frequency of spontane-
ous chromosomal aberrations and bleomycin sensitivity.
2. The relationships between DNA repair gene polymorphisms and markers of
styrene exposure.
3. DNA repair gene polymorphisms as risk factors for upper aerodigestive tract
cancers.
11
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Figure I. Current view of genotoxin metabolism, repair of induced DNA lesions, and
relationships between the measurable end-points or possible outcomes. BER, base
excision repair; NER, nucleotide excision repair; HR, homologous recombination repair;
NHEJ, non-homologous end-joining; and SCE, sister chromatid exchange. Superscripts
refer to the articles included in this study.
genotoxin
excretion
excretion
metabolism 1,2
DNA adduct
DNA-strand break 4 replication fork stalling
chromosomal aberrations 1,2,4
cancer 3 cell apoptosis
BER 1,2,4 / NER 4
BER 1,2,4 HR 1-3
SCE 2
HR 1-3NHEJ
single-base
deletions
cell apoptosis
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2. Cytogenetic damage
2.1 Chromosome aberrations
CAs are present in normal circulating lymphocytes of healthy individuals, but in rather
low frequencies. Several models of radiation-induced CA formation have been de-
duced, as reviewed by Savage (1998). Put briefly, the breakage-and-reunion theory
(“Classic theory”) assumes that radiation induces breaks in “chromonema”, the chro-
mosome backbone, and if two breaks exist close in space and time, they can inter-
act to produce visible structural exchange aberrations (Lea et al., 1942; Lea 1946).
The exchange theory (“Revell theory”), which challenged the classic theory a few
decades back, suggests that the primary damage induced by radiation is not a break
in the chromosome backbone, but an unstable lesion, the nature of which is unde-
fined (Revell, 1955). If these unstable lesions interact in a suitable manner, they may
enter into a state of exchange initiation, which in turn can lead to the formation of
aberrations. One of the differences between the models is that the exchange theory
predicts that the reversal of exchange is possible, something neither permitted nor
possible with the Classic theory. In summary, the Classic theory states “no break–no
exchange” whereas the Revell theory contradicts it by claiming “no exchange–no
break”. The molecular theory (Chadwick et al., 1978) combines the earlier statistical
and cytological observations with modern knowledge of chromosome structure. This
theory argues that the primary unstable lesion in the DNA is a double-strand break
(DSB). This forms CAs by a recombinational process, which enzymatically induces
a second DSB at the recombination point leading to reciprocal translocations. How-
ever, emergency situations may force the cell to use partial homology, which can
lead to the formation of incomplete (non-reciprocal) translocations. Furthermore,
the use of ultrasoft carbon X-rays has suggested that only one DSB is needed for the
formation of simple aberrations (Savage, 1998). Ultrasoft carbon X-rays deposit their
energy in the range of the diameter of one DNA double helix, and are very unlikely
to induce DSBs in more than one DNA helix. However, the exact mechanisms of
aberration formation are still largely unknown. For example, it is not known wheth-
er the break is a true discontinuity in the DNA, whether some material is missing or
whether it is just an uncondensed region of DNA possibly undergoing DNA repair.
The mechanisms for radiation- and chemical-induced CAs may be different, al-
though they may look similar under the microscope. Most chemicals do not directly
induce DSBs, which must, therefore, be caused by the actions of the cell itself. There-
fore, the most probable mechanism for DSB formation is disturbance in the DNA
repair system.
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CAs, as viewed through a microscope on a metaphase preparation, are end prod-
ucts of complex cellular systems. Metaphase chromosomes can be produced by
colchicin (or its analogue Colcemid) arrest during cell division of cycling cells; CAs
are normally scored from non-banded (“solid”), stained metaphase preparations of
lymphocytes stimulated to divide by a mitogen. Radiation-induced damage can be
observed as chromosome- or chromatid-type aberrations, depending on whether
the cell resided in G0/G1 or G2 phase of the cell cycle, respectively, at the time of
irradiation.
According to the most cited theory, breakage-and-reunion, misrepair of illegiti-
mate rejoining of break-ends produces structural aberrations between two different
chromosomes (interchanges) or within one chromosome (intrachanges) (Savage,
1975). In the case of an asymmetrical interchange, the centromeres of both chromo-
somes are located on the same piece, and an accompanying acentric fragment is
present. This dicentric chromosome is easily recognizable after conventional stain-
ing. Reciprocal translocation involves mutual exchange of chromatin pieces, and
only large rearrangements can be detected in solid stained preparations. If two breaks
are located within one chromosome, one on each side of centromere, an easily
observable ring chromosome can be produced. Pericentric inversion formed from
the same lesion cannot usually be distinguished by solid staining. In cases where
breaks remain dissociated, terminal or interstitial deletions are formed. The terminal
deletions can be detected as acentric fragments, whereas interstitial deletions ap-
pear as either small double minutes or acentric rings.
The radiation- or chemical-induced CAs can be classified as chromatid-type or
chromosome-type aberrations (Savage, 1975). Deletions are seen as chromatid- and
chromosome-type breaks (Figure II), the former affecting one chromatid and the
latter both sister chromatids at the same site. Dicentrics, ring chromosomes and double
minutes are classified as chromosome-type aberrations, whereas chromatid-type
aberrations include symmetrical and asymmetrical exchanges within a chromosome
(intrachanges) and between two or more chromosomes (interchanges).
Several polymorphisms of xenobiotic metabolizing enzyme (XME) genes have
been reported to affect spontaneous CA frequency in human peripheral blood lym-
phocyte cultures. Smokers lacking the GSTM1 gene (GSTM1 null individuals) ap-
peared to have higher CA frequencies than those with the gene; the influence of
GSTM1 genotype was restricted to chromatid-type aberrations (Scarpato et al., 1996;
Scarpato et al., 1997). In addition, four individuals deficient for both GSTM1 and
GSTT1 genes showed significantly higher CA counts than the GSTM1 positive and
GSTT1 null individuals (Scarpato et al., 1997). These findings may be explained by
the reduced detoxification capacity of individuals lacking both of the genes.
Nonsmoking bus drivers concurrently lacking the GSTM1 gene and having the
NAT2 slow acetylator genotype had an increased frequency of cells with CAs. Postal
14
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Figure II. Microphotographs of sister chromatid exchanges (A), a chromatid break (B)
and a chromosome break (C) in metaphase chromosomes. The arrows indicate the
diagnostic lesions in the chromosomes. Images B and C, courtesy of Hilkka Järventaus.
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workers (low exposure group, nonsmokers) with slow acetylator NAT2 genotype
also showed elevated CA counts (Knudsen et al., 1999). Smokers with NAT2 rapid
acetylator genotype displayed more CAs (translocations) in their cultured lympho-
cytes than the slow acetylator genotype carriers (Pluth et al., 2000). This difference
was observed in six individuals over 60 years of age of whom four were GSTM1
null. The findings on NAT2 may, at first sight, seem contradictory, but it is possible
that the difference in the alleged risk genotype reflects the difference in genotoxic
exposure between smokers and nonsmokers.
Based on two reviews addressing the effect of different XME polymorphisms on
cytogenetic damage, GSTM1 seems to affect CA frequency especially in smokers
and individuals exposed to polyaromatic hydrocarbons or polluted air, while NAT2
and possibly GSTT1 could affect the baseline level of CAs (Norppa, 1997; Norppa,
2000). This reflects the importance of activation/inactivation metabolism in geno-
toxicity as well as the functionality of XME polymorphisms.
2.2 Sister chromatid exchanges
SCEs occur normally in replicating cells (Tice et al., 1976). They originate from ap-
parently homologous intrachromosomal recombination involving both chromatids
(Figure II). SCEs are induced, e.g., by UV-irradiation (Vogel et al., 1978), alkylating
agents and other adduct-forming chemicals, and virus infections (Latt, 1981). Also
DSBs produced by restriction enzymes electroporated into cells are potent SCE in-
ducers (Natarajan et al., 1985). Enzymes leaving a cohesive end into DNA are less
potent inducers of SCEs than enzymes leaving a blunt DNA end (Darroudi et al.,
1989), probably because cellular repair systems may be more efficient in fixing co-
hesive DSBs.
The exact mechanism of SCE formation is still unclear, but some success has
recently been achieved in unraveling the problem. In a murine Ku70-deletant fibro-
blast cell line, SCE frequency was significantly increased compared with the wild
type cell line (Li et al., 1998). Ku70 is a DNA end-binding protein involved in DSB
repair. Abolishment of homologous recombination in vertebrate cells leads to a
decrease in SCE frequency (Sonoda et al., 1999), suggesting that SCEs are formed
by homologous recombination. However, the SCE formation was not entirely blocked
by the Rad-gene deletion constructed in the cell line. These data indicate that SCEs
are probably initiated by unrepaired DSBs formed during the G1 phase of the cell
cycle. It is also plausible that unrepaired DNA adducts induce DSBs during DNA
replication when the replication machinery gets stuck in the adduct in the S phase
of the cell cycle. DSBs are then repaired during the S phase by homologous recom-
bination repair, which leads to the formation of SCEs. It has been proposed that
16
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homologous recombination may reactivate stalled replication forks (Cox et al., 2000).
Thus, SCEs may actually be an indirect measure of successful DNA repair.
2.3 Bleomycin sensitivity assay
Cultured lymphocytes of normal individuals and cancer patients differ in mutagen
sensitivity: a higher percentage of cancer patients than normal individuals have been
shown to display a high frequency of chromatid breaks (Figure II) in cultured lym-
phocytes when treated with the cancer drug bleomycin (Hsu et al., 1985). However,
some recent observations indicate that this is not necessarily the case in all condi-
tions (Szekely et al., 2003). Bleomycin sensitivity does not correlate with the spon-
taneous frequency of CAs, indicating that different mechanisms are involved in the
formation of bleomycin-induced and spontaneous CAs (Hsu et al., 1985).
Bleomycin sensitivity is normally expressed as a frequency of chromatid breaks
per cell (b/c). Donors are classified as non-sensitive, sensitive or hypersensitive on
the basis of individual b/c. The b/c ratio is elevated in colon, head and neck, and
lung cancer, but not in breast cancer. Old smokers are less sensitive than young
smokers, but in general, smoking habits do not affect the test outcome (Hsu et al.,
1989).
2.3.1 Genetic basis of bleomycin sensitivity assay
It has been hypothesized that bleomycin sensitivity is an inherited trait and could
thus be used to assess individual cancer risk (Hsu et al., 1985). This hypothesis has
been supported by a twin study reporting a heritability of 75% for the bleomycin
sensitivity (Cloos et al., 1999). Because b/c distribution is continuous, it is conceiv-
able that bleomycin sensitivity is a multigenic trait possibly characterized by a single
major gene effect.
Bleomycin needs to be metabolically activated to be able to exert its genotoxic
effects. Bleomycin is probably activated in a cytochrome P450 reductase-dependent
reaction to a reactive Fe(II)⋅bleomycin complex (Scheulen et al., 1981; Kilkushie et
al., 1984; Povirk et al., 1991). Its inactivation is mainly catalyzed by bleomycin hy-
drolase, a cysteine proteinase enzyme. It has been postulated that in some cancers
resistance to bleomycin treatment results from overactive bleomycin hydrolase
(Umezawa et al., 1974; Sebti et al., 1991). Furthermore, in the bacterium Streptomy-
ces verticillus, the bleomycin-producing species, bleomycin is inactivated by NAT
(Matsuo et al., 1997; Sugiyama et al., 1994). In Chinese hamster ovary cells, the lack
of functional GST alpha may result in hypersensitivity to bleomycin (Giaccia et al.,
1991). This lead Kocabas et al. (2000) to hypothesize that GSTM1 defect in humans
17
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might predispose to hypersensitivity to bleomycin. However, their findings were
negative.
2.3.2 Bleomycin-induced DNA damage
The activated Fe(II)⋅bleomycin complex reacts with oxygen to form an extremely
short-lived product that is believed to abstract hydrogen from C-4’ of deoxyribose.
Hydroxylation of this initial lesion results in sugar ring opening and base release
leaving a chemically modified apurinic/apyrimidinic (AP) site. In addition to these
single lesions, bleomycin specifically induces DSBs. DSBs are probably formed with
single-hit kinetics (Povirk et al., 1991). The bleomycin-induced DSB possesses a
complex structure similar to that produced by oxidative processes and ionizing ra-
diation. Bleomycin DSBs are composed of blunt ends or ends containing a single 5'-
base overhang. Regardless of the 5'-end structure, all bleomycin-induced DSBs pos-
sess 3'-ends blocked by phosphoglycolate (Pastwa et al., 2001).
The repair of bleomycin-induced base damage is complicated. The AP site is
probably first cleaved by human AP endonuclease Ape1 (Xu et al., 1998), which
generates 3’-OH and 5’-terminal deoxyribose-5-phosphate (5’-dRp) (Chen et al., 1991;
Wilson et al. 1995). The resulting 5’-dRp can be removed by intrinsic activity of DNA
polymerase beta (Matsumoto et al., 1995), followed by DNA repair synthesis to fill
the gap, and ligation to complete the repair process. Thus, bleomycin-induced base-
damage is repaired by base-excision repair.
DSBs are rejoined probably by various mechanisms. In brief, bleomycin forms
OH-radicals that damage DNA, inducing single-strand breaks (SSBs) similarly to the
X-ray induced DNA damage. Bleomycin may thus induce primarily base damage or
SSBs, and only rarely DSBs; the probability for two SSBs localizing closely together
(to form a DSB) is very small. The DSBs formed by bleomycin are probably gener-
ated by enzymatic reactions from primary lesions, i.e., SSBs.
Bleomycin-induced strand breaks are probably repaired at least by non-homol-
ogous end joining (NHEJ). When the expression of Ku80 (Belenkov et al., 2002) or
Ku70 (Omori et al., 2002) was blocked in cultured human malignant glioma and
lung carcinoma cells, respectively, the cells were sensitized to the effects of bleomy-
cin. In asyncronized cell cultures, most cells are in the cell cycle phase G1, where
NHEJ is active. Therefore, the results do not exclude the possibility that homolo-
gous recombination is also actively repairing bleomycin induced damage in the G2
phase.
Two Chinese hamster cell lines, xrs5 and xrs6, were both found to be more sen-
sitive than wild-type cells to the induction of CAs by bleomycin (Darroudi et al.,
1989). These cell lines are defective in NHEJ of DSB repair (Jeggo, 1998), missing
essential proteins Ku70 and Ku80, respectively. Cells treated with bleomycin have
18
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numerous single-base deletions at the sites of DSBs. This further indicates that the
bleomycin-induced DSBs are repaired via the NHEJ route (Yu et al., 2002). Thus,
DSB repair, especially NHEJ, seems to participate in the repair of bleomycin-induced
DNA lesions.
2.3.3 Bleomycin-induced chromosomal damage
The effect of bleomycin on chromosomes has been extensively reviewed (Vig et al.,
1978; Povirk et al., 1991). Briefly, bleomycin was found to produce both chromo-
some- and chromatid-type aberrations (deletions, dicentrics, rings, exchanges, breaks
and gaps) in all systems studied. Based on the reviewed results, it was concluded
that bleomycin acted on chromosomes in an S-independent fashion since bleomy-
cin produced aberrations regardless of the moment it was administered during the
interphase. Furthermore, the types of aberrations produced by treatment in various
phases of the cell cycle were those expected to result from the production of both
double- and single-strand breaks by bleomycin. In the bleomycin sensitivity assay,
bleomycin induces practically only chromatid breaks and gaps (Hsu et al., 1989),
probably because most of the cells are in the G1 phase of the cell cycle when treat-
ed with bleomycin for 6 hours at 66 hours of culture; the time period may be too
short for effective induction of other types of CAs.
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3. Cytogenetic damage and cancer risk
3.1 Chromosomal aberrations and cancer risk
An inter-European prospective study has assessed the possible cancer risk predic-
tivity of cytogenetic endpoints, namely SCEs, micronuclei (MNs) and CAs. After
trichotomization (high, medium, low), a high frequency of CAs predicts increased
cancer risk. In different countries, the risk of cancer (standardized incidence or
mortality ratio) varied from 1.8 to 2.4 for individuals with a high frequency of CAs
compared with low-frequency individuals. MN and SCE frequencies were not pre-
dictive of cancer risk (Hagmar et al., 1994). MN and SCE frequencies were more
difficult to trichotomize than CAs, because their variation between different sam-
plings from the same individual was big compared with that observed in the CA
frequencies. Furthermore, CAs in lymphocytes predicted human cancer risk inde-
pendently of exposure to carcinogens (Bonassi et al., 2000). Also, the time elapsed
between sampling for the CA-test and the cancer diagnosis did not affect the cancer
predictivity. It is not resolved which CA type is the best predictor of cancer risk, but
a Taiwanese case-control study (22+22 subjects) suggested that chromosome-type
aberrations are a better predictor than chromatid-type aberrations (Liou et al., 1999).
Especially chromosome breaks had good predictive power. The recent report from
the inter-European prospective study including data on 3554 individuals also indi-
cates that both chromatid- and chromosome-type aberrations are predictive of fu-
ture cancer risk, although chromosome-type aberrations have a better predictive
power (Hagmar, 2004).
3.2 Bleomycin sensitivity and head and neck cancer
Primary cancers of pharynx, larynx and oral cavity are classified as head and neck
cancers. In the original study of Hsu et al. (1989), 72.75% of head and neck cancer
patients were sensitive to bleomycin, whereas only 22.69% of controls were classi-
fied as sensitive. In further studies, 53.8% of cancer patients and 25.7% of healthy
individuals were considered sensitive.
Environmental factors modified the cancer risk in the case-control study of Cloos
et al. (1996). Smokers (more than 20 cigarettes a day for 25 years, i.e., 25 pack-
years) and alcoholics (more than 75 ml of absolute ethanol daily) with a high b/c
value were at the highest risk of head and neck cancer. Smokers using alcohol and
displaying a high b/c frequency were at almost 60-fold risk of this malignancy com-
pared with non-smokers not using alcohol and having a low b/c value. However,
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alcohol consumption and smoking are well-established risk factors for head and
neck cancers. Without environmental exposure the cancer risk for bleomycin sensi-
tive individual varied from 3.6 to 5.8 (Spitz et al., 1989). In a group of head and neck
cancer patients, never-smokers were significantly more likely (61.1%) to be mutagen
sensitive than current smokers (35.6%) (Spitz et al., 1997).
Bleomycin sensitivity can also be used to predict tumor recurrence. In patients
with high b/c, cancer was more likely (11.5%) to recur than in individuals with a
lower b/c value (5.3%) (Spitz et al., 1998).
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4. DNA repair
Because the viability of the cell is dependent on the physical integrity of its DNA,
many versatile DNA repair pathways capable of repairing nearly all kind of damag-
es have evolved. Many of them are best characterized in bacteria, like Escherichia
coli, but have begun to be better understood also in mammalian cells. Some of the
possible pathways do not even exist in bacterial cells. The same is also true vice
versa, the existence of several pathways in mammalian cells is a highly disputed
topic (Lewin, 1999).
If the DNA lesion is not repaired and the cell does not undergo apoptosis, the
damage can lead to mutations in crucial genes and ultimately to cancer initiation
and uncontrolled growth. In the following chapters, the DNA repair pathways rele-
vant to the thesis are discussed in more detail.
4.1 Base excision repair
Base excision repair (BER) is the main pathway for the repair of simple DNA lesions
that do not distort the DNA structure, unlike most lesions caused by reactive oxygen
species. Thus, BER enzymes recognize relatively few but frequent lesions (Parikh et
al., 1999). There are at least three pathways for BER coupled repair (Klungland et
al., 1999; Lindahl, 2000).
The first step in all BER pathways is the cleavage of the base-sugar bond (cata-
lyzed by DNA glycosylase), followed by DNA incision by a separate repair enzyme
(AP endonuclease) at the resulting abasic site (Lindahl, 1976). In mammalian cells,
DNA polymerase beta, X-ray cross complementing group 1 (XRCC1), and DNA li-
gase III are responsible for the dominating one-nucleotide replacement pathway. In
the main pathway, DNA polymerase beta accounts both for the gap-filling synthetic
step and the removal of a 5’-terminal abasic sugar-phosphate residue; the latter
excision function appears to be a rate-limiting step in the repair reaction (Srivastava
et al., 1998).
Long-patch BER uses an alternating pathway. After the removal of the damaged
nucleotide, flap endonuclease (FEN1) and proliferative cell nuclear antigen (PCNA)
proceed with the polymerase beta (gaps of 2–6 bps) or polymerase gamma (gaps of
2–13 bps) to synthesize new DNA. The nicks in DNA are sealed by XRCC1 and
DNA ligase III complex (gaps of 2–6 bps) or DNA ligase I (gaps of 2–13 bps) (Wil-
son, 1998).
The repair of oxidative damage in pyrimidines (pyrimidine glycols) probably uses
another pathway where a spesific DNA glycosylase called hNth1 removes the cyto-
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toxic lesion. XPD protein is probably needed in this reaction (Klungland et al., 1999)
as a loading factor for hNth1 in human cells (Lindahl, 2000). Also another kind of
oxidative damage, 8-hydroxyguanine, has its own glycosylase, 8-oxoguanine glyc-
osylase (OGG1), which removes damaged bases from DNA (Monden et al., 1999).
The main BER pathway repairs SSBs formed by enzymatic cleavage, gamma-
rays, or chemicals like bleomycin, H
2
O
2
, nitrogen oxide (NO), and etoposide. XRCC1
has a central role in the main pathway. It has no enzymatic activity by itself, but
rather functions as a loading factor for polymerase beta and ligase III (Thompson et
al., 2000). BER is active in the G1 phase of cell cycle, but also in the G2 phase (Ot-
terlei et al., 1999).
4.2 Nucleotide excision repair
In contrast to BER, one protein complex in NER is probably responsible for repair-
ing a large number of different DNA lesions. NER is thought to be mainly involved
in the repair of bulky lesions, such as benzo[a]pyrene (B[a]P) adducts, which distort
the conformation of the DNA helix. NER is so far the only known mechanism in the
human body that removes the major UV-induced photo lesions (Wood, 1999). Also
small lesions caused by reactive oxygen species (ROS) can possibly be repaired by
NER (Reardon et al., 1997).
NER is not essential for cellular or animal viability, and individuals with the in-
herited syndrome, xeroderma pigmentosum (XP), have a total deficiency in this
pathway. Such patients usually have roughly a 1,000-fold increase in the incidence
of skin cancers and their mean life span is only about 50 years. XP patients have
impairing mutations in one (or more) of the XP genes. Another disease, Cockayne
syndrome, is also characterized by cutaneous photosensitivity. Cockayne syndrome
is a rare disorder in which people are sensitive to sunlight, have short stature, and
appearance of premature aging. The genetic defect seems to be in the transcription
coupled NER (Lawrence et al., 1999; Boer et al., 2000). Trichothiodystrophy (TTD)
is the third syndrome classified under the same family of diseases. It is characterized
by photosensitivity, ichthyosis, brittle hair, intellectual impairment, decreased fertil-
ity, and short stature. The genetic defect of TTD is localized in the XPD (ERCC2),
but the involved gene region differs from that mutated in XP (Boer et al., 2000).
In humans, more than 25 different proteins involved in NER have been described
to date. The separate steps in NER can be divided into DNA damage recognition,
DNA unwinding, 3’- and 5’-incision, patch repair synthesis, and ligation. The main
proteins include XPA and RPA (replication protein A, damage recognition), TFIIH
(transcription factor II H) complex including XPB and XPD (DNA unwinding heli-
case and ATPase), XPC (DNA binding), XPF (5’ nuclease), XPG (3’ nuclease), RFC
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(replication factor C), PCNA and polymerase epsilon (repair synthesis), and ligase I
(nick sealing) (Lehmann, 1995; Lehmann, 1998; Sancar, 1996; Wood, 1996).
4.3 Transcription coupled repair
Transcription coupled repair (TCR) repairs DNA lesions preferentially located in the
transcribed strand. TFIIH, which is central to NER, is also essential for the TCR path-
way. The role of TFIIH is to guide the repair to the transcribed DNA strand. Further-
more, TFIIH probably also loads RNA polymerase II onto the damaged DNA, which
is an initiative step in the TCR repair pathway (Mullenders, 1998).
TCR is usually classified as a subpathway of NER, but this view is changing. It is
now thought that Cockayne syndrome patients, who have a defect in TCR, are un-
able to repair oxidative DNA damage irrespective of its nature. Thus, it was hypoth-
esized that TCR might be the main pathway for recognition of oxidative DNA dam-
age, directing the further repair of either BER or NER pathways (Hanawalt, 2000).
This explanation is also consistent with the clinical symptoms (photosensitivity) dis-
played by Cockayne syndrome patients.
4.4 Double-strand break repair
Double strand break (DSB) repair corrects DNA breaks affecting both strands of the
double helix. Three different DSB repair pathways have been identified in mamma-
lian cells. Their relative importance for cell survival is probably significant, because
DSBs are difficult lesions for cells to repair, and small differences in this ability may
make the difference between cell survival and apoptosis. DSBs are very rarely, if at
all, generated by endogenous oxidative damage and are therefore unlikely to rep-
resent a spontaneous lesion of any significance. DSBs are, however, sometimes in-
troduced by endonucleases into specific sites and are repaired by specific DSB re-
pair mechanisms. Mutants defective in defined repair mechanisms may therefore be
defective in these normal metabolic processes. These repair mechanisms and their
potential to induce CAs has recently been reviewed (Pfeiffer et al., 2000).
4.4.1 Non-homologous end-joining (NHEJ)
Non-homologous end-joining (NHEJ) is a repair pathway using a short stretch of
homology as a guide to ligate the cleaved DNA ends together. A blunt ligation is
also possible, but less efficient. About ten proteins are known to participate in the
NHEJ repair. The process can be divided into three steps. First, the DSB is recog-
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nized by Ku70 and Ku80 proteins, and the signal of DNA lesion is mediated by DNA-
protein kinase (DNA-PK) to begin the repair processes. In the next step, MRE11 and
NBS1 are recruited to the DNA lesion and in the last phase, DNA ligase IV stimulat-
ed by XRCC4 seals the DNA ends together (Critchlow et al., 1998; Jeggo 1998; Sin-
gleton et al., 1999).
In mammalian cells, NHEJ is probably the main repair pathway for DSBs, at least
in the G1 phase of the cell cycle. Because cells rather use sister chromatids than
homologous chromosomes for recombinational repair, it is conceivable that the activity
of homologous recombination repair is low in the G1 phase. It has been shown that
non-homologous recombination occurs between 100 to 10,000 times more frequently
than homologous mechanisms in mammalian cells (Singleton et al., 1999). NHEJ is
not a totally accurate repair pathway. It can lead to small deletions or insertions of
a few base pairs. These mutations are probably much less critical for cell survival
than a persisting DSB.
Two genetic disorders are characterized by the lack of effective NHEJ. Nijmegen
breakage syndrome patients display an elevated level of CAs and other clinical symp-
toms. Mutations in the NBS1 (Nijmegen breakage syndrome 1) gene are responsible
for the syndrome (Ito et al., 1999). An ataxia telangiectasia-like disorder is caused by
a missense mutation in another crucial NHEJ gene, MRE11 (meiotic recombination
11) (Michelson et al., 2000).
4.4.2 Single-strand annealing (SSA)
Single-strand annealing (SSA) is involved in the DSB-induced recombination between
long direct repeats, e.g., short (SINE) or long (LINE) interspersed nuclear elements.
SSA in mammalian cells was first proposed to account for non-conservative recom-
bination products detected after the transfection of DNA into mouse cells (Lin et al.,
1984). The details of SSA are poorly characterized in mammalians, but are better
known in yeast, Saccharomyces cerevisiae (Singleton et al., 1999, Jeggo 1998). SSA
in yeast is independent of RAD50 (radiation sensitivity 50), which is essentially needed
for efficient homologous recombination. SSA recombination is initiated by a DSB,
but the break does not need to be within the region of homology. The DNA ends
are degraded by a strand-specific endonuclease to reveal single-stranded direct re-
peat sequences. The homologous regions realign and the 3’ single-stranded over-
hanging tails are removed. In S. cerevisiae this is performed by RAD1/RAD10 com-
plex. Recombination is completed by repair synthesis and ligation (Singleton et al.,
1999). Mammalian homologs of RAD1 and RAD10, XPF (ERCC4) and ERCC1, have
been identified and are likely to operate in a similar way (van Duin et al., 1986;
Brookman et al., 1996; Sijbers et al., 1996).
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An important feature of the SSA pathway is that sequences are always lost dur-
ing the process, in contrast to the conservative nature of homologous recombina-
tion. Therefore, the SSA mechanism is very error-prone.
4.4.3 Homologous recombination repair (HR)
Homologous recombination repair (HR) has two totally different roles in cells. It
can be used to increase genetic variation in meiosis and also to maintain genomic
stability in mitotic cells by repairing chromosome breaks using the sister chromatid
as a template. The existence of HR in mammalian cells has been disputed until late-
ly. Recent studies with chicken B lymphocyte line DT40 have shown that HR is an
essential DNA repair pathway (Sonoda et al., 1998). RAD51-deficient cells accumu-
late chromosomal damage, especially breaks, before stalling at the G2/M phase of
the cell cycle and going into apoptosis. In yeast, the HR process is dependent on
the RAD52 epistasis group of genes (Singleton et al., 1999). Recently, mammalian
homologs (XRCC2 and XRCC3) of RAD50, RAD51, RAD52, and RAD54 have been
identified and cloned, underlining the evolutionary importance of homologous re-
combination (Shinohara et al., 1993; Muris et al., 1994; Petrini et al., 1995; Dolganov
et al., 1996; Kanaar et al., 1996; Baumann et al., 1998).
DSB is processed to reveal single-stranded regions of DNA. RAD51p together
with the single-stranded DNA-binding protein (SSB) coats the single-stranded DNA
to form a nucleoprotein filament. This filament searches for a homologous sequence
in the genome and invades the donor duplex to form a joint molecule. The DNA
gap is repaired by fill-in synthesis using the donor strand as template, followed by
branch migration, resolution of Holliday junction, and the release of DNA mole-
cules (Singleton et al., 1999). In general, HR repair works the same way as normal
HR (Lewin, 1999), but the proteins involved are somewhat different.
Expression of human RAD51p and RAD52p appears to be the lowest during the
G1 phase of the cell cycle and upregulated during late S/G2 (Chen et al., 1997).
Targeted knockout of rad51 in mouse results in early embryonic lethality, indicat-
ing an essential role in mouse development in addition to a role in DSB repair (Lim
et al., 1996). HR has also other important functions in cells than just the repair of
replicated DNA. It has been hypothesized that HR may be mainly involved in the
reactivation of stalled replication forks (Cox et al., 2000).
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4.5 DNA repair genes XRCC1, XRCC2, XRCC3, XPC, XPD
and XPG
4.5.1 XRCC1
XRCC1 (X-ray cross complementing group I) was the first cloned mammalian gene
involved in correcting DNA damage from X-rays or ionizing radiation (Thompson
et al., 1990). The XRCC1 gene is located on chromosome 19q13.2. The gene is spread
over a region of more than 32 kbs, and it has 17 exons. Human XRCC1 protein is
composed of 633 amino acids.
Three polymorphisms (Arg194Trp, Arg280His, Arg399Gln) resulting in amino acid
substitutions were originally identified in the coding region of the XRCC1 gene (Shen
et al., 1998). The substitutions are located in amino acids conserved during evolu-
tion. The polymorphism of codon 399 is located in the BRCT1 interaction domain of
the XRCC1 protein, but others are situated in the spacer regions (Figure III).
Figure III. The domain structure of the DNA repair proteins XRCC1, XRCC2, and
XRCC3. The positions of the best characterized amino acid substitution polymorphism
have been marked with arrows.
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Several novel non-synonymous amino acid substitution polymorphisms have
recently been shown to exist on the coding region of XRCC1 gene. Val72Ala poly-
morphism was initially identified in sequence databases (Tuimala et al., 2001), and
quickly verified by laboratory studies (Mohrenweiser et al., 2002, and Ruttan et al.,
2002). The 72Ala variant allele frequency in Caucasian population has been reported
to be 2–11%, making it the fourth most common amino acid polymorphism in XRCC1.
It is located in the N-terminal part of XRCC1, and has potential phenotypic effects.
With the exception of the tentative Lys51STOP polymorphism (2%), the frequency of
all other substitutions has been reported to be less than 1% (Mohrenweiser et al.,
2002, and Ruttan et al., 2002).
XRCC1 is implicated in DNA repair based on its DNA repair capacity in the Chinese
hamster ovary cell line EM9 (Thompson et al., 1990). EM9 is hypersensitive to ethyl
methanesulfate (EMS) and X-rays, exhibits elevated levels of SCEs, and has a longer
half-life of SSBs induced by EMS (Thompson et al., 1982), and a reduced efficiency
of HR (Hoy et al., 1984). XRCC1 expression has to date been described in murine,
rat, and baboon tissues but not in human tissues (Walter et al., 1994; Yoo et al.,
1992; Zhou et al., 1995). Testis was found to express XRCC1 at significantly higher
levels than other tissues in mouse and rat. In baboon, testis and ovary expressed the
XRCC1 gene in large amounts, lymph nodes in intermediate, and liver and kidney
in small amounts.
Human XRCC1 exerts no enzymatic activity by itself (Thompson et al., 2000),
but directs the assembly of short patch base-excision repair machinery on DNA (Rice,
1999). Three interaction domains have been identified in the human XRCC1 gene
(Figure III). They bind DNA polymerase beta (Kubota et al., 1996), poly (ADP-ri-
bose) polymerase (PARP) (Masson et al., 1998), and DNA ligase III (Nash et al., 1997).
Furthermore, the N-terminal end of XRCC1 binds specifically SSBs in DNA (both
gapped and nicked) (Marintchev et al., 1999).
XRCC1 has a central role in short patch base-excision repair. After damage rec-
ognition and initial incision of DNA by monofunctional glycosylases, XRCC1 binds
to nicked or gapped DNA (Rice, 1999; Thompson et al., 2000). XRCC1 can probably
bind to nicks or gaps induced by various chemicals, e.g., bleomycin, directly with-
out the incision step. XRCC1 loads DNA polymerase beta on the nick or the gap, the
polymerase synthesizes new DNA, and DNA ligase III recruited by XRCC1 seals the
resulting nick (Thompson et al., 2000).
A recent study suggested that XRCC1 regulates the activity of PARP (Masson et
al., 1998). The binding of PARP and XRCC1 to damaged DNA may therefore be
mutually competing processes. If XRCC1 binds to single-stranded DNA, it inhibits
PARP activity; PARP needs to bind to nicked or gapped DNA in order to be activat-
ed. This hypothesis is supported by findings of Masson et al. (1998).
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The role of PARP in base excision repair is not well characterized. PARP is a zinc-
finger DNA-binding protein that detects and signals DNA strand breaks generated
directly or indirectly by genotoxic agents. In response to these lesions, the immedi-
ate poly(ADP-ribosylation) of nuclear proteins converts DNA interruptions into in-
tracellular signals that activate DNA repair or programmed cellular death. Studies on
PARP knockout mice demonstrate the importance of PARP in recovery from DNA
damage that triggers BER (Dantzer et al., 1999). Thus, the role of PARP in BER may
be to regulate the repair activity.
To date, several reports on the phenotypic significance of the XRCC1 polymor-
phisms have been published. Healthy carriers of the XRCC1 399Gln variant allele
displayed an elevation in the levels of both the aflatoxin B
1
-DNA adducts in blood
lymphocytes and the glycophorin A variant erythrocytes (Lunn et al., 1999), sponta-
neous frequency of SCEs (Duell et al., 2000), higher smoking-related SCEs (Lei et
al., 2002), and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) -induced SCE
frequencies in cultured lymphocytes (Abdel-Rahman et al., 2000). Heterozygous
carriers of 194Trp variant allele also showed slightly elevated NNK-induced SCE fre-
quencies, but the difference did not reach statistical significance. However, the vari-
ant allele carriers had lower SCE levels at all three NNK concentrations, which im-
plies that also codon 194 polymorphism may have a modulating effect on the XRCC1
activity (Abdel-Rahman et al., 2000).
Three studies assessed the frequency of B[a]P or smoking-related DNA adducts
in the carriers of XRCC1 399Gln allele (Matullo et al., 2001a, 2001b; Pastorelli et al.,
2002). All the studies reported negative results, although there was a tendency for
higher DNA adduct levels in the carriers of 399Gln allele (Pastorelli et al., 2001; Mat-
ullo et al., 2001b). The negative results may partly be due to small sample sizes (small
number of carriers of variant allele) in these studies. The 399Gln allele may also be
associated with ionizing radiation sensitivity (Hu et al., 2001).
In conclusion, XRCC1 codon 399 polymorphism might be associated with ele-
vated levels of SCEs, which are probably formed by homologous recombination
from DNA double-strand breaks, but not with the frequencies of bulky DNA ad-
ducts, which are probably more efficiently repaired by NER or HR.
The phenotypic effects on DNA repair rates or association with cancer risk of
the novel polymorphisms, like Val72Ala, has not been studied.
4.5.2 XRCC2
XRCC2 (X-ray cross complementing group II) is a Rad51 paralogue, and plays a
pivotal role in the homologous recombination repair machinery (Cartwright et al.,
1998; Dosanjh et al., 1998). XRCC2 consists of three exons, which are distributed
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over a 30 kb region in the chromosome 7q36.1. The length of the transcript is 307
amino acids.
To date, one amino acid substitution polymorphism has been described on the
coding region of XRCC2 gene (Mohrenweiser et al., 2002), resulting in Arg188His amino
acid substitution (Figure III). The potential phenotypic effects of this polymorphism
are currently unknown.
The Chinese hamster ionizing radiation-sensitive cell line (irs1) lacking XRCC2
was shown to display extreme sensitivity to DNA cross-linking agents and genomic
instability (Cartwright et al., 1998). The XRCC2 therefore seems to promote chromo-
somal stability in cells, but is not essential for viability of cultured cells (Liu et al.,
1998; Cui et al., 1999). On the other hand, XRCC2-defective mice do not develop
normally (Deans et al., 2000).
XRCC2 promotes the repair of DSBs by HR (Johnson et al., 1999). It is also of
paramount importance in the repair of DNA cross-links. NER repair is capable of
removing cross-links from DNA, but HR, not non-homologous end-joining, is need-
ed to repair the NER-induced DSBs (De Silva et al., 2000). XRCC2 might also be
involved in the control of genomic rearrangement processes leading to chromatid
breaks (Mozdarani et al., 2001). There is, however, some controversy on the meth-
odology of the study, specifically on the problems in scoring radiation-induced
chromatid breaks (Thacker et al., 2002).
4.5.3 XRCC3
XRCC3 (X-ray cross complementing group III) gene was originally identified by its
ability to complement the DNA repair defect in a Chinese hamster cell line (Jones et
al., 1987; Fuller et al., 1988, Tebbs et al., 1995). It is located on chromosome 14q32.3,
where its seven exons lie in the region taking 13.5 kbs. XRCC3 is a small protein of
346 amino acids.
A substitution of C to A has been characterized in the coding region of human
XRCC3 (Shen et al., 1998). It results in Thr241Met amino acid change (Figure III). The
XRCC3 Met/Met genotype has been associated with higher DNA adduct levels in
lymphocytes of healthy subjects (Matullo et al., 2001). However, this effect is likely
not caused by a defect in homology-directed DSB repair; individuals with 241Met or
241Thr allele repaired the DSBs to the same extent (Araujo et al., 2002).
The XRCC3-deficient Chinese hamster cell line irs1SF is moderately sensitive to
X-ray, gamma and UV-radiation, and EMS (Jones et al., 1987; Fuller et al., 1988). The
cell line also shows extreme sensitivity to DNA cross-linking agents, such as mito-
mycin C (Jones et al., 1987; Tebbs et al., 1995) and has increased rates of spontane-
ous and X-ray induced chromatid and chromosome breaks (Fuller et al., 1988; Tebbs
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et al., 1988). Sequence analysis of the XRCC3 gene has revealed a homology to the
recombinational repair gene RAD51 (Liu et al., 1998).
XRCC3 is required for chromosome stability in Chinese hamster cells (Cui et al.,
1999). Cell lines without XRCC3 activity displayed highly elevated levels of dele-
tions, breaks, and especially translocations. The number of deletions and transloca-
tion was also cumulative through extended passage of the cell lines. XRCC3 is re-
quired for the efficient repair of DNA and chromosome breaks by homologous re-
combination (Brenneman et al., 2000). These findings support the original hypoth-
esis that XRCC3 is involved in homologous recombination repair of DSBs.
Furthermore, XRCC3, and therefore also HR, is required for efficient and correct
chromosome segregation (Griffin et al., 2000). It is probable that XRCC3 is an asses-
sory protein required for efficient HR repair.
4.5.4 XPC
XPC (xeroderma pigmentosum group C complementing protein), a protein consist-
ing of 937 amino acids, guides the NER machinery to the damaged site by binding
to the DNA. The XPC gene is located in chromosome 3p25. Its 19 exons are distrib-
uted over a region of 33.4 kbs.
In addition to alternative splicing forms of mRNA (Khan et al., 2002), a A2920C
polymorphism in exon 15, resulting in Lys939Gln amino acid substitution, has been
described in the XPC gene (Khan et al., 2000). The Lys939Gln substitution does not
appear to affect the DNA repair capacity measured by a post–UV host cell reactiva-
tion assay (Khan et al., 2000). Post-UV host cell reactivation assay measures how
effectively cells remove UV-damaged nucleotides from DNA.
4.5.5 XPD
XPD (xeroderma pigmentosum group D complementing protein), an enzyme con-
sisting of 759 amino acids, acts as a DNA unwinding helicase and ATPase during
nucleotide excision repair. The XPD gene consists of 22 exons, and takes about
18.8 kbs in chromosome 19q13.3.
Several polymorphisms are located in the XPD gene (Broughton et al., 1996;
Shen et al., 1998). The A to C base change in exon 23, resulting in Lys751Gln amino
acid substitution, is especially interesting; this substitution appears to have clear
phenotypic consequences. The Lys751Gln polymorphism is in strong linkage dise-
quilibrium with the Asp312Asn polymorphism located in the seven-motif helicase
domain of the RecQ family of DNA helicases (Shen et al., 1998). Thus, for evalua-
tion of the effects of these substitutions, investigation of the codon 751 polymor-
phism is anticipated to be sufficient.
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After X-ray treatment, individuals, or rather their cells, with the Lys/Lys genotype
exhibited about four times as many chromatid aberrations (breaks and gaps) as other
individuals. The effect was equally profound in both breaks and gaps (Lunn et al.,
2000). The CAT (a bacterial drug resistance gene) -gene-based host reactivation as-
say of B[a]P-treated plasmids indicates that lung cancer patients having the Gln/Gln-
genotype might have lower DNA repair capacity (Spitz et al., 2001). A similar study
conducted on healthy subjects showed that the 751Gln allele delays the rate of DNA
adduct removal (Qiao et al., 2002). Studies based on healthy subjects exposed to
traffic pollution or city air suggest that the carriers of at least one 751Gln allele have
higher levels of bulky DNA adducts, although smoking might regulate the effect
(Matullo et al., 2001; Palli et al., 2001).
4.5.6 XPG
XPG (xeroderma pigmentosum group G complementing protein) acts as a 3’-endo-
nuclease in the nucleotide excision repair. XPG gene is located on chromosome
13q22, where its two exons occupy 3.4 kbs. The transcript is 67 amino acids long.
In addition to six splice variants, three amino acid substitution polymorphisms
have been identified in the coding region of the XPG gene. Only one of the substi-
tutions, i.e., the Asp1104His substitution resulting from C3507G base change in exon
15, has been experimentally verified, and occurs in polymorphic frequencies (>1%)
in the Caucasian population (Emmert et al., 2001).
Because XPG acts as a 3’-endonuclease in the nucleotide excision repair, it might
have profound effects on the capacity to repair bulky DNA adducts, but the 3507C
and 3507G alleles do not seem to differ in their capacity to remove crosslinking dimers
(TT=C or TT=T) from the DNA (Kumar, et al., 2003).
4.6 DNA repair genes and cancer risk
Since most of the DNA repair genes and their polymorphisms have been identified
only lately, their relevance to cancer risk has been quite scarcely explored to date.
XRCC1, polymorphisms of which were among the earliest reported, is an exception
in this regard. The results of numerous molecular epidemiological studies conduct-
ed on XRCC1 genotypes and susceptibility to cancer have been summarized in Ta-
ble I.
A recent epidemiological meta-analysis review revealed that only a few of the so
far published studies are large and population-based. The XRCC1 codon 194 vari-
ant allele appeared to be consistently associated with decreased cancer risk, where-
as the results for the XRCC1 codon 399 genotypes were inconclusive (Goode et al.,
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2002). When a combined risk for399Gln allele was calculated on the basis of the
published studies (Table I, unpublished data), a study-corrected (combined risk
divided by the number of studies) odds ratio (OR) was estimated to be about 1.4
(statistically not significant). If the number of subjects included in the studies was
also considered (combined risk divided by the number of subjects), the risk was
practically abolished (OR=1.04, statistically not significant).
Recent studies have reported a positive association between XRCC3 241Met allele
and melanoma (Winsey et al., 2000), bladder cancer (Matullo et al., 2001; Stern et
al., 2002), squamous cell carcinoma of head and neck (Shen et al., 2002), and breast
cancer (Smith et al., 2003). In contrast, the findings on lung cancer have been neg-
ative (David-Beabes et al., 2001; Hu et al., 2002; Misra et al., 2003).
Two studies linked the XRCC2 188His allele to increased risk of breast cancer
with ORs of 2.6 (95% CI=1.0–6.7) and 1.3 (95% CI=1.0–3.8), respectively (Kuschel et
al., 2002; Rafii et al., 2002).
The epidemiological approaches may contain some uncertainties in sorting out
the risk alleles that possibly affect also DNA repair activity. For instance, if the DNA
of the cell is badly damaged and cannot be repaired, another solution for the cell is
to go into apoptosis. Therefore, if the defect in the DNA repair gene preferentially
results in apoptosis of damaged cells, the risk allele may be falsely deduced from
the epidemiological data.
The aforementioned epidemiological studies suggest that polymorphisms in
XRCC1, XRCC2, and XRCC3 genes may contribute to individual cancer susceptibil-
ity. Even more interesting would be to know the impact of combined effects of variant
alleles in, e.g., both the BER and NER enzyme genes. These studies would, howev-
er, require very large study sizes due to the rarity of some of the variant alleles in
both repair pathways.
To date there are no published data available on the potential association be-
tween XPC exon 15 polymorphism and individual cancer proneness. In contrast,
the XPD exon 23 Lys-genotype has been linked to elevated risk of basal cell carci-
noma (Dybdahl et al., 1999), head and neck cancer (Sturgis et al., 2000), and lung
cancer (Hou et al., 2002). The Lys allele may also be a risk factor for basal cell car-
cinoma (statistically non-significant findings, [Dybdahl et al., 1999]). The Gln allele
seems to predispose individuals to cancers of head and neck and lung.
The XPG exon 15 polymorphism has been linked to susceptibility to breast can-
cer (Kumar, et al., 2003). Carriers of the XPG 1104Asp allele exhibited a slightly elevat-
ed risk of breast cancer (OR=1.33, 95% CI=1.0–1.8). The combined risk for homo-
and heterozygous carriers of the Asp allele was even a bit higher (OR=1.50, 95%
CI=1.04–2.16).
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Table I. Summary of the results from studies assessing the role of XRCC1
genotypes in the risk of different cancers
Codon 194 Codon 280 Codon 399
Arg Trp Arg His Arg Gln
Lung cancer1 - - - + - -
Lung cancer14 - - - - - -
Lung cancer18 + - o o - -
Lung cancer19 o o o o - +
Lung cancer22 - - o o - -
Non-melanoma skin cancer2 o o o o - +
Head and neck cancer3 + - o o - +
Head and neck cancer4, 20 - - o o + -
Adenocarcinoma of lungs5 o o o o - +
Bladder cancer6 - - o o - +
Colorectal cancer7 - + o o - +
Prostate cancer8 - - o o - -
Breast cancer9 - - o o - +
Breat cancer10 - - o o - +
Esophageal cancer11 - - - - + -
Esophageal cancer12 + - o o - -
Gastric cancer13 + - o o - -
Gastric cancer15 - - - - - -
Pancreatic adenocarcinoma16 o o o o - +
Myoloblastic leukemia17 - - o o + -
Lymphoblastic leukemia21 - - o o o o
+ denotes a risk allele for the cancer, and – denotes a (concomittant) non-risk allele. o denotes
the allele not included in the study.
1 Ratnasinghe et al., 2000, 2001;2 Nelson et al., 2000, 2002; 3 Sturgis et al., 1999; 4
Watson et al., 2000; 5 Divine et al., 2000, 2001; 6 Stern et al., 2000, 2001, 2002; 7
Abdel-Rahman et al., 2000; 8 Hu et al., 2000; 9 Duell et al., 2000, 2001; 10 Kim et al.,
2002; 11 Lee et al., 2001; 12 Xing et al., 2002; 13 Shen et al., 2000; 14 Butkiewick et al.,
2001; 15 Lee et al., 2002; 16 Duell et al., 2002; 17 Seedhouse et al., 2002; 18 David-
Beabes; 19 Park et al., 2002; 20 Olshan et al., 2002; 21 Krajinovic et al., 2002; 22 Chen et
al., 2002.
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5. Xenobiotic metabolism
Enzymes involved in the metabolism of foreign compounds are classically divided
into phase I and phase II enzymes. Phase I XMEs including, e.g., cytochrome P450
mono-oxygenases (CYPs), introduce or release a functional group of metabolized
compound by an oxidation, hydroxylation, or reduction reaction so that the original
compound becomes more water-soluble. Phase II XME enzymes further metabolize
these compounds by conjugating a sulfate-, glutathione-, amino acid-, acetyl-, or
glucuronide group to the metabolized compound. Phase II enzymes are usually
classified as detoxifying enzymes, because the end products are generally less reac-
tive and can be more easily excreted (Amdur et al., 1991).
5.1 Glutathione S-transferases
Glutathione S-transferases (GSTs) form a superfamily of enzymes catalyzing conju-
gation of the tripeptide glutathione with compounds containing electrophilic car-
bon atoms (Strange et al., 2000). GSTs have been further divided into several fam-
ilies; to date, six cytosolic (alpha, mu, phi, theta, sigma and zeta), and two mem-
brane-bound (microsomal and leukotriene C4) GST families have been identified
(Strange et al., 2000). Because glutathione conjugation can prevent potentially harmful
xenobiotics from binding to cellular constituents, it has a central role in the antiox-
idant defence. Sometimes the cellular glutathione balance can be altered by toxic
compounds, which can lead to drastic deleterious results like lipid peroxidation and
cellular death (Amdur et al., 1991).
To date, genetic polymorphisms have been found in six of the cytosolic GSTs,
i.e., in GSTA2, GSTM1, GSTM3, GSTP1, GSTT1 and GSTZ1 (Tetlow et al., 2001; Strange
et al., 2000). The most studied polymorphic GST genes are GSTM1 and GSTT1; about
50% of Caucasians completely lack GSTM1 activity due to a homozygous deletion
of the gene (Board, 1981), and 10–20% are carriers of a homozygous deletion of
GSTT1 gene (Pemble et al., 1994). Both GSTs are supposedly expressed in human
peripheral blood lymphocytes, but only GSTT1 is expressed in red blood cells (Schro-
der et al., 1996). However, GSTM1 and GSTP1 predominate in hematopoietic lym-
phoid cells, whereas GSTT1 expression is relatively the greatest in erythroid lines
but absent in 60% of presumably (by genotype) positive erythroid cell lines (Wang
et al., 2000). How these findings correlate with expression in mature blood cells is
still unclear.
The correlation between genetic polymorphisms and respective enzyme activity
is naturally best characterized for GSTM1 and GSTT1; lack of the gene (deletion)
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results in total absence of the respective enzyme activities. For other GSTs the gen-
otype-phenotype relationships are much less accurate.
5.2 N-acetyltransferases
N-acetyltransferases (NATs) are cytosolic enzymes catalyzing the acetylation of amines.
Especially important substrates for NATs are aromatic amines present, e.g., in dyes,
pesticides, food, and tobacco smoke. Depending on the metabolic balance of the
target tissue, NATs may either activate (O-acetylation) or inactivate (N-acetylation)
arylamine carcinogens. In humans, two genes, NAT1 and NAT2 are responsible for
N-acetylation of xenobiotics. Both NAT1 and NAT2 catalyze N- and O-acetylation
and the enzymes have partly overlapping substrate specificity (Kadlubar et al., 1992).
In humans, NAT2 is the predominant form in liver, whereas NAT1 dominates in nearly
all other tissues. NAT1 activity in whole blood is about 9–10 times higher than NAT2
activity (Risch et al., 1996). Both NAT1 and NAT2 are polymorphic in humans. Sev-
eral polymorphisms have been idenfied in the NAT1 gene (for nomenclature see
Vatsis et al., 1995), but since only polymorphisms of the NAT2 gene were consid-
ered in this thesis, they will not be discussed in more detail here.
The NAT2 genotype can be used to interprete the individual enzymatic acetyla-
tor status (slow/rapid) (Cascorbi et al., 1995 and 1999). Carriers of at least one copy
of the NAT2 wild type allele (NAT2*4) are considered as rapid acetylators. About
50% of Caucasians have two NAT2 variant alleles (slow acetylator genotype) and
therefore exhibit decreased NAT2 enzyme activity. To date, several defective NAT2
variant alleles have been described (Vatsis et al., 1995; Grant et al., 1997; Hein, 2000).
Five of the variant alleles (*5A, *5B, *5B, *6A and *7A) account for over 95% of the
slow NAT2 acetylator genotypes in Caucasians (Cascorbi et al., 1995; Cascorbi et al.,
1999).
5.3 Bleomycin hydrolase
Bleomycin hydrolase (BLHX) is a proteinase belonging to the papain superfamily
(Sebti et al., 1989). It was originally isolated from rabbits and mice based on its
enzymatic activity to render bleomycin to its inactive metabolite (Umezawa et al.,
1974). These findings led the authors to suggest that drug inactivation could play a
major role in tumor resistance to bleomycin treatment (Sebti et al., 1991).
Because BLHX is a housekeeping gene (GC-rich promoter sequence, no TATA-
box), it is widely expressed in all tissues (Brömme et al., 1996; Ferrando et al. 1996).
It has been shown to be especially heavily expressed in head and neck cancers
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(Ferrando et al., 1996). However, results on BLHX expression in human blood leu-
cocytes are inconsistent. While Ferrando et al. (1996) reported a strong expression
of BLHX in healthy donor’s leukocytes, Brömme et al. (1996) found no expression
at all. BLHX is expressed in human leukemias (Brömme et al., 1996), which may
reflect the presense of the enzyme only in stimulated leukocytes.
So far one polymorphisms in the coding region of BLHX gene has been identi-
fied (Brömme et al., 1996). The A1450G substitution results in Val to Ile amino acid
change in the carboxy-terminal end of the protein. Val in this position is highly
conserved during evolution; it is the normal amino acid in humans, rat, chicken,
yeast, and even a few bacterial species (Koldamova et al., 1998). Furthermore, the
last eight amino acids are essential for the BLHX and aminopeptidase activity. The
Val to Ile substitution takes place only four amino acids upstream from the essential
amino acids (Koldamova et al., 1998). The C-terminus is also required for protection
of bleomycin-induced chromosomal damage (Lefterov et al., 1998). The phenotyp-
ic changes induced by substitution in the BLHX gene have not been studied, but it
is conceivable that the substitution may affect the enzyme activity by interrupting
the essential C-terminal amino acid sequence. Furthermore, the variant allele was
associated with the risk of sporadic Alzheimer’s disease (Montoya et al., 1998). Be-
cause BLHX also seems to have a regulatory role in the metabolic cascade possibly
leading to Alzheimer’s disease (Lefterov et al., 2000), the polymorphism may indeed
affect the enzyme activity.
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6. Exposures studied
Two model compounds of occupational exposures are introduced here, styrene and
tobacco-smoke. Styrene is a good model compond for genotoxicology studies, be-
cause it is widely used, exposures remain high in reinforced plastics industry, and
its toxicology, metabolism and other properties are very well characterized. Tobac-
co-smoke is a common (occupational) exposure, and an often used model mixture
for genotoxicology studies.
6.1 Styrene
Styrene (ethenylbenzene, C
8
H
8
, CAS no. 100-42-5) is one of the most important or-
ganic chemicals, and is widely used in the production of plastics, synthetic rubber,
and polyester resins. Styrene is mainly produced to prepare solid polystyrene foam,
which is used as an insulation material in buildings and water pipes. Styrene is also
an environmental contaminant. It can enter the environment during production, use
or disposal of styrene-based products. It is present in small quantities in food items,
tobacco smoke, engine exhausts, air, water, and soil (IARC, 1994).
6.1.1 Styrene carcinogenicity and genotoxicity
Although the evidence of styrene’s carcinogenicity in humans is either inadequate
or contradictory, and the evidence for animal carcinogenicity limited, IARC has clas-
sified styrene as a possible human carcinogen (group 2B). The principal styrene
metabolite, styrene-7,8-oxide (SO), is classified as a probable human carcinogen
(group 2A). Styrene gives positive results in many genotoxicology assays (Norppa
et al., 1988; Barale, 1991; Tates et al., 1994; Vodicka et al., 1995; Somorovská et al.,
1999).
Most studies concerning reinforced plastic workers exposed to styrene have
reported an increased frequency of CAs in peripheral blood lymphocytes (WHO
2000). Cohort studies have not been able to demonstrate an association between
styrene exposure and cancer, with the possible exception of leukemias and lym-
phomas (McMichael et al., 1976; Hodgson et al., 1985; Bond et al., 1992).
6.1.2 Styrene exposure
Humans are exposed to styrene primarily via inhalation of contaminated air during
the manufacturing processes of reinforced plastics (Pfäffli, 1982). Occupational ex-
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posure in hand lamination work may intail a daily intake of several grams of styrene
via inhalation. Styrene is also easily adsorbed through the skin. Styrene is soluble in
water (or blood) and accumulates in adipose tissues (Wolff et al., 1977).
6.1.3 Styrene metabolism
Styrene is genotoxic after metabolic activation and its most important reactive me-
tabolite seems to be SO, an alkylating agent found to be genotoxic in several test
systems. For example, styrene has given only positive results in genotoxicity assays
with human whole-blood lymphocyte cultures. The effects are probably due to the
metabolic activation of styrene to SO in the presence of erytrocytes (Belvedere et
al., 1981; Norppa et al., 1983; Jantunen et al., 1986).
Styrene metabolism has been extensively reviewed (IARC, 1994; Vodic˘ka, et al.,
2002). Briefly, in humans styrene is oxidized by cytochrome P450-enzymes or oxy-
haemoglobin to SO, which is a strong reactive intermediate; SO reacts readily with
nucleic acids to form various DNA adducts, mainly O6-deoxyguanosine and N7-
deoxyguanosine. SO is metabolically inactivated by microsomal epoxide hydrolase
(EPHX1) and excreted into urine as mandelic and phenylglyoxylic acids. These acids
are the primary metabolites quantitated in the biomonitoring of styrene exposed
humans.
To a minor extent, SO is conjugated with glutathione, resulting in the subse-
quent formation of phenyl hydroxyethyl mercapturic acids (PHEMAS). An alterna-
tive minor route is oxidation on the aromatic ring, which may lead to the formation
of 3,4-arene oxide, thought to contribute to styrene genotoxicity (Pfäffli et al., 1981;
Watabe et al., 1982). The above described metabolic pathways may be followed by
measuring the urinary concentrations of mercapturic acids and 4-vinyl phenol.
6.1.4 DNA repair and styrene
Styrene induces DNA strand breaks in human white blood cells (Brenner et al., 1991;
Walles et al., 1993; Somorovská et al., 1999; Vodic˘ka et al., 1999). The repair of DNA
strand breaks in cultured cells exposed to SO is rapid: the lesions are effectively
removed from the DNA within a few hours after the treatment (Laffon et al., 2002).
On the other hand, DNA adducts, expecially at O6 position of guanosine, formed by
SO, are very persistent, and not very effectively repaired; they were detectable in
cultured human lymphocytes even eight days after the treatment (Bastlova et al.,
1995). SO seems to induce many more strand breaks than DNA adducts at consen-
trations viable for cultured cells (Bastlova et al., 1995). Cytogenetic damage (SCEs
and CAs) is another consequence of styrene exposure (Tates et al., 1994; Somorovská
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et al., 1999). Base excision and oxidative lesion repair seem to be elevated in sty-
rene exposed workers (Vodicka et al., 2002), suggesting that DNA excision repair
mechanisms may be critical in protecting cells from the adverse effects of styrene
metabolites.
These data indicate that styrene and SO primarily induce strand breaks that are
rapidly repaired. It is possible that some strand breaks remain, and in such cases
CAs may be induced in order to sustain the unity of the damaged DNA. It is also
plausible that some persistent bulky adducts formed by SO prevent the transcrip-
tion of the DNA, which might lead to DNA strand breaks and subsequent CAs, or to
the reactivation of damaged replication forks that might correspond to the forma-
tion of SCEs. This hypothesis is supported by the known mechanism of action of
SO; CAs induced by SO are formed during the S-phase of the cell cycle.
6.2. Cigarette smoke
Cigarette smoke is a highly complex mixture of more than 3,800 compounds. There
are at least 20 compounds that have been convincingly found to induce tumours,
including benzene, aromatic amines, and PAHs (Hecht, 1999). PAHs and aromatic
amines are probably the main carcinogens in tobacco smoke. Moreover, the tar content
of cigarettes correlates with the risk of developing upper digestive tract neoplasms
(Gallus et al., 2003). It is presently unclear, whether tar is the principal source of
genotoxic compounds in cigarette smoke.
Some compounds identified from cigarette smoke can generate reactive oxygen
species, which are capable of inducing DSBs in the DNA (Jaloszynski et al., 2003).
The oxygen radicals are likely to play a central role in the development of lung
cancer (Marnett et al., 2000), and might also contribute to the formation of upper-
aerodigestive tract cancers (UAT). PAHs and aromatic amines in cigarette smoke might
also form DNA adducts, which can be converted into DNA strand breaks. There-
fore, it is plausible that the DNA repair of both strand breaks and DNA adducts is
implicated in cigarette smoke exposure, and therefore also in UAT cancers.
UAT cancers, i.e., oral, pharyngeal, and laryngeal cancers, claimed 30,504 vic-
tims in the European Union during 1998 (IARC, 1998). The UAT cancers are more
prevalent in men than in women (IARC, 1998) and are strongly associated with al-
cohol and tobacco consumption (Johnson, 2001; Risch et al., 2003; Gallus et al., 2003).
The standardized incidence for all the three cancers was 20.51 / 100 000 individuals.
The standardized mortality was 13.74 / 100,000 individuals. Laryngeal cancer has a
higher mortality than the cancers of oral or pharyngeal origin, probably because its
diagnosis is often delayed. For some reason, France has much higher UAT incidence
and mortality rates than other European countries.
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The UAT cancers comprise mostly of squamous cell carcinomas, which might
partly explain the strong association of these cancers with the consumption of stim-
ulants; epithelium is mainly of squamous type in mouth, pharynx and larynx.
Because PAHs and aromatic amines undergo an extensive metabolism, and most
of the relevant XMEs are polymorphic, the possible role of the xenobiotic metabo-
lism in the UAT cancers has been studied earlier. It has been shown, using the same
French population that has been used in the epidemiological study included in this
thesis, that certain polymorphisms of GSTM3, P1, and T1, EPHX1, and NAT2 are
risk factors for UAT cancers (Jourenkova-Mironova et al., 1999a, 1999b, 1999c, 2000)
Since May 2000, tobacco smoke has been classified as an occupational cancer
hazard in Finland. All workers who are occupationally exposed to tobacco smoke
for more than 40 days annually must now be reported to the ASA register (Finnish
register of workers exposed to carcinogens). ASA register holds records of workers
exposed to cancer promoting chemicals in Finland.
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II Present study
1. Aims of the study
The major objective of this thesis was to determine if DNA repair gene polymor-
phisms could affect individual sensitivity to genotoxic effects and cancer.
More specifically, the overall aims were:
1. To evaluate the influence of different xenobiotic metabolizing and DNA repair
enzyme polymorphisms on the outcome of bleomycin sensitivity assay.
2. To evaluate the effect of genetic polymorphisms of XRCC1 and XRCC3 DNA
repair genes on the frequency of spontaneous CAs in short-term culture of
human lymphocytes.
3. To analyze whether DNA repair genotypes modify the risk of UAT cancers in
smokers.
4. To investigate whether DNA repair gene polymorphisms affect the levels of
genotoxicity biomarkers in occupational exposure to styrene.
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2. Subjects and methods
2.1 Study subjects
Four different Caucasian study populations were investigated in this work (Table
II). Finnish and Hungarian populations were used to study the effect of DNA repair
gene polymorphisms on CAs and SCEs. A Czech cohort was used to study the effect
of DNA repair gene polymorphisms on the genotoxicity end-points in styrene ex-
posure. A French population was used to study the possible role of DNA repair
gene polymorphisms in susceptibility to cancers of the upper aerodigestive tract in
smokers. These populations were chosen for this work because of their relevance
to the studied hypothesis, and because we had ongoing collaboration with the lab-
oratories providing the material.
2.1.1 Finnish study population
The Finnish subjects, who were originally used as controls in a study on isocyanate
asthma (Piirilä et al., 2001), were mainly office workers and secretaries, but also
included were a few chemists, and other people who possibly had been exposed to
isocyanates at very small amounts. Although relatively many of the study subjects
(34.4%) were smokers, their smoking dose appeared to be rather low (mean 8.1
pack-years). Most (84%) of the subjects were males, because they acted as a control
group for factory workers consisting mainly of men. All the subjects were healthy at
the time of blood donation.
2.1.2 Hungarian study population
The Hungarian study subjects were recruited at the Hungarian National Cancer In-
stitute, Budapest. Originally, they had participated in a case-control study of head
and neck cancer (Szekely et al., 2003). Smoking was about as frequent in the Hun-
garian controls (39%) as in the Finnish controls. Most of the Hungarian subjects (73.0%)
were males.
2.1.3 Czech study population
The styrene-exposed group consisted of 86 workers employed at three different plants
located in the same area. The control group consisted of employees of a Regional
Hygienic Station and unexposed maintenance workers from one of the three plants.
Smoking was more common in the exposed group (51.2%) than in the control group
(19.1%).
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2.1.4 French study population
The French study subjects were recruited from 10 French hospitals between 1988
and 1992. Of these subjects, 250 were cancer patients. Peripheral blood samples
were available from 121 patients with cancers of the oral cavity or pharynx, and 129
patients with cancers of the larynx. Only incident cases with histologically confirmed
squamous cell carcinoma were included. The control group consisted of individuals
without previous or current malignant disease. The control group was age- sex-,
and hospital-matched with the cancer patients. Only regular smokers, defined as
people having smoked at least five cigarettes a day for at least five years, were in-
cluded in the study. Most of the study subjects were men (95–96% of cases and
controls). A more detailed description of the study population has been published
previously (Jourenkova-Miranova, 1999).
2.2 Blood samples and DNA isolation
For cell culture purposes, 10ml of peripheral blood was collected into heparinized
Vacutainer® tubes, and whole-blood lymphocyte cultures were established within
24 hours of blood sampling. For genotyping purposes, DNA was isolated by stan-
dard phenol-chloroform method (Blin et al., 1976) from buffy coats of peripheral
blood samples collected into EDTA Vacutainer® tubes and stored at –20OC until use.
2.3. Styrene exposure
To assess personal exposure to styrene, ambient air was sampled by personal do-
simeters (Paper IV) (Vodic˘ka et al., 1995 and Somorovská et al., 1999). In addition,
the concentration of styrene in blood was determined (Vodic˘ka et al., 2001).
2.4 Chromosomal aberrations and mutagen sensitivity
assay
The mutagen (bleomycin) sensitivity assay (Paper I) was performed for the Hungar-
ian study group essentially as described in previous work (Schantz et al., 1989; Hsu
et al., 1989). In brief, standard lymphocyte cultures were established in RPMI 1640
medium. On the third day of the culture, the cells were treated with bleomycin (30
mg/ml) for five hours. During the last hour, the cells were treated with Colcemid
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(0.05 mg/ml) to accumulate mitosis prior to harvest for conventional air-dried
metaphase preparations. Control cultures, from which the spontaneous CA-frequency
was scored, received only the one-hour Colcemid treatment. The slides were coded
and stained with Giemsa without banding. 50 metaphases per sample were scored
for CAs (control cultures) or for bleomycin-induced chromosome breaks (chroma-
tid breaks and exchanges). The frequency of bleomycin-induced breakage was
expressed as breaks per cell (b/c) for purposes of comparison.
For the cytogenetic studies performed in Finland, peripheral blood cell cultures
were set up (Papers I, II and IV) as had been previously described, with 48-hour
and 72-hour culture times for CAs and SCEs, respectively (Valjus et al., 1993). One
hundred cells per donor were microscopically scored for the CA analysis and 30
cells per donor for the SCE analysis.
2.5. Single-strand breaks and DNA repair capacities
Alkylation-specific DNA damage was detected by a modified single-cell gel electro-
phoresis (Comet) assay (Collins et al., 1996). The comet assay is based on the alka-
line lysis of labile DNA at sites of damage. The unwound, relaxed DNA is able to
migrate out of the cell during electrophoresis and can be visualized with fluorescent
DAPI-staining. Cells that have accumulated DNA damage appear as fluorescent comets
with tails of DNA fragmentation or unwinding, whereas normal undamaged DNA
does not migrate far from the origin. Abasic sites and oxopyrimidines were detected
with the Comet assay after endonuclease III treatment (Collins et al., 1996 and 2001).
Repair of irradiation-specific DNA strand breaks was performed according to
Alapetite et al., 1999. Agarose embedded cells were irradiated with γ-rays and either
lysed immediately or incubated at +37oC for 40 minutes. The level of SSBs was de-
termined at both time points by the Comet assay, and the decrease in SSBs occur-
ring during the incubation was used as a measure of DNA repair capacity (Vodicka
et al., 2002).
The individual capacity of mononuclear leukocyte extracts to repair 8-oxogua-
nine, known to be removed from DNA by a specific glycosylase OGG1, was deter-
mined as had been previously explained (Collins et al., 2001). In brief, HeLa cells
were pretreated with the photosensitizer Ro 19-8022 (Hoffmann-La Roche) and irra-
diated with a fluorescent lamp to induce 8-oxoguanine. Aliquots of cell extracts
prepared from mononuclear leukocytes were incubated on microscopic slides to-
gether with the pretreated HeLa cells, and mounted in agarose for the Comet assay.
The level of SSBs in the HeLa cells reflected the removal of 8-oxoguanine from HeLa
cell DNA by the leukocyte extract.
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2.6 Genotype analyses
2.6.1 BLHX
The original genotyping method for BLHX was based on single-strand conforma-
tion polymorphism (SSCP) analysis (Montoya et al., 1998). This is a rather laborous
technique if numerous samples are to be prosessed. Therefore, we designed a nov-
el PCR and RFLP (PCR-RFLP) -based method for the genotype analysis (Paper I).
The nucleotide substitution together with the mismatch incorporated in the forward
primer creates a MunI restriction digestion site. The primers used were BLHX-G
(forward) CCT GGA TCT GTC CTT TGC AGC TAC G and BLHX11R (reverse) GCT
GTG TTA GAG CAG GAA CCC AAT T. This primer pair (6 pmols of each primer)
amplifies a DNA fragment of 130 bps under the standard PCR conditions with the
following program: denaturing 94 OC 30 seconds, annealing 58 OC 30 seconds and
elongation 72 OC 15 seconds for 35 cycles. After digestion with 5 U of enzyme and
3% agarose gel electrophoresis, the A/A genotype gives a fragment of 130 bps, the
A/I genotype fragments of 130, 106 and 24 bps and the I/I genotype fragments of
106 and 24 bps.
2.6.2 GST
In GSTM1 and GSTT1 genotyping analysis (Paper I, II and IV), the gene-specific
primer pairs were used together with a third pair for b-globin in a multiplex reac-
tion. The absence of GSTM1 and/or GSTT1 specific PCR-product indicated the cor-
responding null genotype while the presence of β-globin specific fragment confirmed
the proper functioning of the reaction (Chen et al., 1996; Hirvonen et al., 1996).
2.6.3 NAT2
The NAT2 genotypes were determined by the method of Bell et al., 1993, which
differentiates between the NAT2 *4, *5, *6 and *7 alleles (Papers I, II, and IV). The
absence of a specific restriction site indicated the presence of a specific variant al-
lele. Individuals having inherited two defective alleles were considered as slow
acetylators. Genotype-phenotype comparisons have indicated that by the method
used, approximately 90% of all the subjects will be correctly classified according to
the acetylation status (Cascorbi et al., 1995).
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2.6.4 XRCC1 and XRCC3
The XRCC1 and XRCC3 genotypes were detected by a PCR-RFLP (restriction frag-
ment length polymorphism) -based technique (Papers I, II, and III). Codon 194 and
399 polymorphisms of XRCC1 were sought as had been previously described (Lunn
et al., 1999) with slightly modified primer sequences; three bases were added to the
end of 26106F primer (codon 194-spesific forward primer) to unify the annealing
temperatures in the multiplex PCR reaction. The absence of the MspI restriction sites
indicated the presence of variant alleles.
For the genotype analyses of XRCC1 codon 280 and XRCC3 codon 241, a mul-
tiplex PCR method was developed. The A280G (Arg280His) nucleotide substitution
abolishes a RsaI cleavage site, and the C241T (Thr241Met) substitution creates a NlaIII
restriction site. The following primers were used to amplify a 280 bp and a 335 bp
fragment of XRCC1 and XRCC3: XRCC1-280F TGG GGC CTG GAT TGC TGG GTC
TG and XRCC1-280R CAG CAC CAC TAC CAC ACC CTG AAG G for codon 280 and
XRCC3-241F GCT CGC CTG GTG GTC ATC GAC TCG and XRCC3-241R AAG AGC
ACA GTC CAG GTC AGC TG for codon 241. PCR conditions consisted of 100–400
ng of genomic DNA, 1.67 mM MgCl
2
, 200 mM each dNTPs, 1 unit of Taq polymerase
(Promega), 10 pmols of each primer in 1 X PCR-buffer (Promega) in a 30ml volume.
A 10 ml aliquot of PCR product was digested with RsaI (New England Biolabs) and
NlaII (New England Biolabs), as suggested by the manufacturer. The DNA fragments
were resolved in 3% agarose. The resulting bands were as follows: codon 280, A/A
genotype 280 bp, A/G genotype 280 bp and 140 bp and G/G genotype 140 bp;
codon 241, C/C genotype 335 bp and 102 bp, C/T genotype 335 bp, 233 bp and 102
bp, and T/T genotype 233 bp and 102 bp.
A method described earlier (Matullo et al., 2001) was used for XRCC1 and XRCC3
genotyping in Paper IV.
2.6.5 XRCC2
In the XRCC2 genotyping analysis (a novel method, Paper III), a 200 bp PCR prod-
uct was amplified from isolated DNA using gene-specific primers (5’-CAG TAG TAG
CAC CCA CTT ACT TC-3’ and 5’-GTT TGT GTC GTT GCA AAA AGA ACC-3’). The
PCR was conducted as follows: 5 min of initial denaturation at 94oC, followed by 34
cycles of 30 sec at 94oC, 30 sec at 60oC, and 60 sec at 72oC, and a fival extension of
5 min at 72oC. Following the PCR, the variant His allele was differentiated from the
wild type Arg allele by the presence of the BstUI (New England Biolabs) restriction
site in the former, which resulted in 173 bp and 27 bp digestion products.
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2.6.6 XPC, XPD, and XPG
The genetic polymorphisms in XPC (exon 15), XPD (exon 23), and XPG (exon 15)
were determined as had been described earlier (Hemminki et al., 2001; Kumar et
al., 2003; Khan et al., 2002).
2.7 Statistical analyses
Prior to statistical analyses, the variables were tested for normality by Kolmogorov-
Smirnof test, normal probability plot and skewness, and kurtosis of the distribution.
Outlying measurements were searched for, e.g., by leverage in a normal probability
plot (Papers I, and II). Student’s t-test and Mann-Whitney’s U test (Papers I, II, and
IV) were used to compare the means of the dependent variables. All statistical tests
were two-sided. SPSS for Windows 9.0 and 10.1.7 (SPSS Inc., Chicago, USA) com-
puter programs were used in the statistical analyses (Papers I and II).
The bleomycin-induced break frequency ratio was calculated by exponentiation
(eb) of the parameter estimate from a linear regression model (Paper I). The ratio
compares the geometric mean break frequency in an exposed group with that in a
referent (unexposed) group, and can be thought of as the adjusted proportional
change in the geometric mean frequency of bleomycin-induced breaks between
the two comparison groups. All final regression models of the mean break frequen-
cy were evaluated for model fit using regression diagnostics including graphical display
of studentized residuals.
For Paper II, the adjusted SCE frequency was calculated by linear regression as
described in Paper I. Because CA frequencies are neither linear nor continuous, but
do not significantly deviate from the Poisson distribution, a log-linear Poisson re-
gression (Bonassi et al., 1994) was used for calculating the adjusted CA frequencies.
Before regression analysis, the CA frequencies of the Finnish and Hungarian study
populations were centered around the same positive integer. After centering, the
populations were combined for succeeding statistical analysis. For Poisson regres-
sion, the relative risks (RIs) and their 95% confidence intervals were calculated us-
ing R 1.5.0 (http://www.r-project.org).
ORs and their 95% CIs were calculated by unconditional logistic regression (Pa-
per III), with sex, age, daily consumption of tobacco, duration of smoking, and daily
consumption of alcohol as confounding factors. The analyses were performed us-
ing STATA package 7.0 (StataCorp LP, College Station, USA). All statistical tests were
two-sided.
Kruskall-Wallis test was employed to test for an association between biomarkers
and the genotypes (Paper IV). The differences between group means were tested
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for statistical significance by Mann-Whitney’s U test. Certain confounders (age, sex,
and smoking, etc.) were also controlled for by the Kruskall-Wallis models. For an
evaluation of the modulating role of genetic polymorphisms on the levels of geno-
toxicity biomarkers, the statistical tests were performed on the whole cohort in or-
der to increase the number of subjects, as suggested by Hemminki and Försti (2002).
The statistical calculations were performed using Statgraphics 7.0 (Manugistics, In.,
Cambridge, USA).
The allele frequencies were tested for Hardy-Weinberg equilibrium by χ2-test.
Yates’ correction for continuity was applied when appropriate.
2.8. Bioinformatics
Several sequence databases, computer programs, and search tools were utilized in
this study. For example, PCR primers were hand-designed using complete gene
sequences retrieved from EMBL database (http://srs.ebi.ac.uk). The binding sites of
the designed PCR primers were verified by BLAST-searches against human sequences
in NR-database (http://www.ncbi.nlm.nih.gov/blast).
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3. Results
3.1 Bleomycin sensitivity studies (Paper I)
The effect of metabolic (GSTM1, GSTT1, NAT2, and BLHX) and DNA repair (XRCC1
and XRCC3) gene polymorphisms on individual bleomycin sensitivity (mean b/c)
was investigated among 80 healthy Caucasian controls. The allele frequencies of all
the genes were in Hardy-Weinberg equilibrium, and did not significantly deviate
from the frequencies reported earlier for Caucasian populations.
Multivariate linear regression model was fit to the data taking into account some
variables relevant for the hypothesis (smoking, age, and sex) and the genotypes.
Separate regression models were constructed for the metabolic and DNA repair genes.
As only a few individuals were homozygous for the variant alleles of XRCC1, XRCC3
or BLHX, they were combined with the heterozygous variant allele carriers for the
statistical analyses in order to increase the power of the study. Based on their NAT2
genotype, the individuals were classified as slow or rapid acetylators. The acetylator
status was used as one variable in the regression models.
We compared regression models with and without one influential observation
(b/c=1.91). After the removal of this influential observation, the b/c frequency dis-
tribution was normalized (skewness 0.22, kurtosis –0.32, Kolmogorov Smirnov 0.067,
and p-value 0.2) which is an obligatory requirement for the statistical model used.
However, the parameter estimates of both of the regression models were not found
to differ materially, and therefore the results for all the 80 subjects are presented.
When bleomycin sensitivity studies are performed, individuals are normally clas-
sified as insensitive, sensitive, and hypersensitive, on the basis of the mean b/c fre-
quency (Hsu et al., 1989). The selection of an appropriate cut-off point for sensitive
and hypersensitive individuals on the basis of the mean b/c frequency is critical for
the interpretation and comparitivity of the results. Usually, cut-off points of 0.8 (50th
percentile of b/c in controls) and 1.0 (75th percentile of b/c in controls) are used for
sensitive and hypersensitive individuals, respectively. We used the same cut-off points,
because the real 50th and 75th percentile calculated from our study group were al-
most the same (0.79 and 0.99, respectively).
3.1.1 Metabolic gene polymorphisms and bleomycin sensitivity
Neither age, sex, smoking status, nor the GSTM1, GSTT1 or NAT2 genotypes were
related to bleomycin sensitivity (see Table II in Paper I). Subjects with the BLHX
normal allele displayed higher mean levels of bleomycin-induced breaks than vari-
ant allele carriers (0.89 versus 0.80, p=0.061, two-sided Mann-Whitney’s test). When
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the subjects were further stratified, the effect of the BLHX genotype appeared to
concern only smokers (0.91 versus 0.78, p=0.036, two-sided Mann-Whitney’s test).
No effect was seen for non-smoking subjects.
3.1.2 DNA repair gene polymorphisms and bleomycin sensitivity
The statistical models were run twice, and all the XRCC1 polymorphisms were tak-
en into account independently or as genotype combinations. The results for the two
models did not differ materially, and the results from the model with independent
polymorphisms are presented.
Age, sex, smoking status, and the XRCC1 and XRCC3 genotypes were not relat-
ed to the bleomycin sensitivity (Table IV). Elevated levels of bleomycin induced
breaks were observed in subjects carrying the XRCC1 codon 280 variant allele (1.01
versus 0.81, p=0.002, two-sided Mann-Whitney’s test). When the effect of the XRCC1
codon 280 polymorphism was adjusted for the age, sex, smoking, and the other
genotypes, the finding was of borderline significance in the regression model
(RR=1.18, 95% CI=0.98–1.41, see Table I in Paper I).
It is also possible that smoking interacts with the XRCC1 codon 280 genotype.
Smokers with the XRCC1 280Arg allele had significantly lower levels of chromatid
breaks in their cultured lymphocytes than the variant allele carriers who did not
smoke (0.79 b/c versus 1.15 b/c, p=0.001, two-sided Mann-Whitney’s test). Howev-
er, the effect was only of borderline significance in the linear regression model
(RR=0.68, 95% CI=0.52–1.01).
3.2 DNA repair gene polymorphisms and cytogenetic
damage (Paper II)
The effect of genetic polymorphisms of XRCC1 and XRCC3 on individual spontane-
ous CA frequency was investigated among 84 and 61 healthy Hungarian and Finn-
ish controls, respectively. The subjects were pooled for the multiple regression anal-
yses.
Age, gender, and smoking were the most important non-genotype related vari-
ables affecting the CA frequency in both populations. Age and smoking influenced
mainly the frequency of gaps and chromatid type aberrations. The frequency of SCEs
was higher in women than in men.
We controlled for the genotypes of GSTM1, GSTT1 and NAT2, because they might
affect smoking-induced (GSTM1) or baseline frequency (GSTT1, NAT2) of SCEs or
CAs. These genotypes were, however, mostly unrelated to the baseline frequency
of SCEs (see Table I in Paper II), although the SCE frequency was slightly (9%) in-
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creased in the GSTT1 null individuals. The GSTT1 and NAT2 genotypes affected the
frequency of chromosome breaks (see Tables IV and V in Paper II).
The XRCC1 and XRCC3 genotypes did not affect the mean frequency of SCEs
(Tables I and II in Paper II). Individuals with the XRCC1 194Trp or 280His alleles had
about 20% less chromatid breaks than the respective homozygous wild type allele
carriers (Table III in Paper II). A similar effect was also seen for chromosome breaks,
but the variant allele carriers had 3–5 times less breaks than the carriers of the wild
type allele (Table III in Paper II). After multiple Poisson regression adjustment for
age, sex, smoking, and genotype, the effects of the XRCC1 genotypes became sig-
nificant for chromosome breaks only (see Table IV in Paper II). Subjects heterozy-
gous for XRCC3 codon 241 variant allele showed about 40% higher frequency of
chromatid-type breaks than wild-type or variant homozygotes, and a statistically
significant effect was obtained in the combined data (Tables III and IV in Paper II).
To further characterize the effect of smoking on CA frequencies, the subjects
were divided into smokers and non-smokers. The GSTM1 null allele was associated
with a statistically significant decrease in the chromatid break frequency in non-
smokers, but not in smokers, where it was linked to the increased number of chro-
matid breaks instead. Similarly, the NAT2 slow acetylator genotype decreased the
frequency of chromosome breaks in non-smokers.
The XRCC1 280His allele decreased the number of chromosome breaks in both
smokers and non-smokers, but the effect reached statistical significance only in
smokers. XRCC1 codon 399 variant allele was statistically significantly associated
with a decreased number of chromatid gaps in non-smokers only.
3.3 DNA repair genes and risk of upper aerodigestive
tract cancers (Paper III and unpublished data)
The association between risk of upper aerodigestive track cancers and the XRCC2
and XRCC3 polymorphisms was studied in a French population. There were 165
controls, 119 oral cavity or pharyngeal cancer patients, and 127 laryngeal cancer
patients available for the study.
The XRCC2 Arg188His and XRCC3 Thr241Met genotype distributions (Table VII)
were in Hardy-Weinberg equilibrium (p=0.88 and p=0.28, respectively). The frequency
of the XRCC2 188His allele (0.07) was comparable to the frequencies reported earlier
(Kuschel et al., 2002; Rafii et al., 2002). The XRCC3 241Met allele frequency (0.45)
was similar to the frequency observed in an Italian population (0.42) (Matullo et al.,
2002), but higher than seen in a US (0.38) (David-Beabes et al., 2001) or UK (0.36)
(Kuschel et al., 2002) population.
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The XRCC2 His allele containing genotypes were associated with a significantly
increased risk of pharyngeal cancer (OR=2.9, 95% CI=1.3–6.2) (Table 2 in article III),
whereas the XRCC2 polymorphism did not modify the risk for oral cavity or laryn-
geal cancers. Neither was any interaction found between alcohol consumption,
smoking and the XRCC2 genotype.
A reduced risk of supraglottic cancers was found in the carriers of XRCC3 241Met
allele (OR=0.1, 95% CI=0.2–0.8) (Table 2 in article III). Moreover, there was a signif-
icant interaction between smoking history and XRCC3 genotype; individuals with
the XRCC3 Met allele containing genotypes and a history of less than 30 years of
smoking had a reduced risk of oral or pharynx cancers (OR=0.3, 95% CI=0.1-0.8).
This effect was not seen in those with a history of more than 30 years of smoking
(OR=1.0, 95% CI=0.5-2.1).
The relationships between cancers of the upper aerodigestive tract and the XRCC2 188
His allele containing genotypes were not modified by the XRCC3 genotypes.
3.4 Styrene-exposed lamination workers (Paper IV and
unpublished data)
Lamination workers had been exposed to rather high concentrations of styrene in
air, determined by personal dosimeters (81.3 mg/m3, 2*SD=56.3 mg/m3, range=4-
223 mg/m3). Finnish occupational hygienic (HTP) value for an 8-hour exposure is
86 mg/m3. Clearly, the HTP value was grossly exceeded in some workers, probably
because of their individual tasks, while some workers were only lightly exposed to
styrene during the measurements. Styrene concentration in blood, a marker of inter-
nal exposure, was on the average 0.56 mg/l (2*SD=0.43 mg/l) in the exposed group
and 0.07 mg/l (2*SD=0.06 mg/l) in the controls (includes some maintenance work-
ers from the styrene lamination plants). The styrene concentrations in the air and
blood correlated significantly (r=0.759, p<0.001) with each other.
The mean frequency of CAs was the highest among the unexposed (external)
controls (3.2, 2*SD=2.0) and the lowest in the exposed (plant) controls (1.7, 2*SD=0.9)
(see Table II in Paper IV). Furthermore, there was no tendency for the more heavily
exposed individuals to display elevated frequencies of CAs, nor did the frequency
of CAs show significant correlation with exposure to styrene (styrene in air or blood).
However, the frequency of CAs correlated positively, but not very strongly, with age
(R=0.215, P=0.018). In non-smokers, the frequency of chromosome breaks was
positively correlated with the leukocyte capacity to incise 8-oxoguanine in DNA
(R=0.388, P=0.005).
The mean level of alkylation-induced single-strand breaks in the DNA was found
to be significantly lower in the exposed group (0.29/109 daltons) than in the con-
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trols (0.57/109 daltons, p<0.001). In addition, the frequency of SSBs correlated in-
versely with the concentration of styrene in the air or blood. In contrast, the level of
abasic sites and oxopyrimidines did not differ between the exposed and unexposed
subjects (0.12 and 0.16 single-strand breaks per 109 daltons, respectively), and did
not significantly correlate with the styrene concentration in the air or blood.
Irradiation-specific DNA repair capacity, which is thought to reflect BER, was
significantly higher in the exposed group than in the unexposed group (1.1 and 0.7
single-strand breaks per 109 daltons, respectively, p=0.002). The repair capacity
correlated significantly with the styrene concentration in the air (r=0.337, p=0.006)
and blood. The 8-oxoguanine-specific DNA repair capacity correlated positively with
the styrene concentration in the air (r=0.375, p=0.001) and blood (r=0.311, p=0.019).
The following genotype results were removed from the published article, as
requested by two anonymous referees. Therefore, the data is presented here. Smokers
with the XRCC1 399Gln variant allele displayed a higher frequency of CAs than car-
riers of the normal allele (r=-0.359, p=0.021; F=3.2, p=0.052). Non-smokers with the
XPD codon 23 variant allele had higher frequencies of chromatid aberrations than
those non-smokers who had the with wild-type allele (r=0.255, p=0.043; F=2.8,
p=0.070).
The level of single-strand breaks was lower in individuals homozygous for the
wild-type alleles of XPC exon 15 or XRCC1 codon 399 (r=0.217, p=0.055 and r=0.251,
p=0.034, respectively) (Figure IV). After stratification by smoking, the effect of XPC
became significant only in smokers (r=0.342, p=0.016) and the effect of XRCC1 only
in nonsmokers (r=-0.483, p=0.029). The level of abasic sites and 8-oxopyrimidines
was modulated by XPG (F=5.3, P=0.009) and XPC (F=4.0, P=0.025) genotypes.
The level of irradiation-specific DNA repair was significantly decreased in ho-
mozygous carriers of the XRCC1 codon 399 variant allele and XPG exon 15 wild-
type allele (Figure IV). The highest DNA repair capacity was found in individuals
with the homozygous wild-type genotype and the lowest in individuals homozy-
gous for the 399Gln allele (R=-0.433, P=0.001). When the subjects were stratified by
smoking, irradiation-specific DNA repair was even more clearly associated with the
XRCC1 codon 399 genotype in non-smokers (r=-0.525, p=0.001; F=5.9, p=0.007),
and also showed an association with XPD (r=-0.400, p=0.012; F=3.5, p=0.040) and
XPG (r=0.349, p=0.050; F=2.9, p=0.071) polymorphisms.
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Figure IV. A: Mean values±SD of irradiation-specific DNA repair rates (expressed as SSB/
109 daltons) stratified by XRCC1 exon 10 genotype. B: Mean values±SD of SSBs (ex-
pressed as SSB/109 daltons) stratified by XRCC1 exon 10 genotype. C: Mean values±SD
of irradiation-specific DNA repair rates (expressed as SSB/109 daltons) stratified by XPG
exon 15 genotype. Groups include both smokers and non-smokers as well as exposed
and unexposed individuals.
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4. Discussion
4.1 Bleomycin sensitivity studies
Bleomycin sensitivity has usually been used as a phenotypic test for increased can-
cer susceptibility. It is commonly thought that bleomycin sensitivity is a trait with a
strong genetic component with an estimated heritability index of 75% (Cloos et al.,
1999). On the basis of a test that measures bleomycin-induced breaks per cell (b/c),
people are usually classified as nonsensitive, sensitive, or hypersensitive. However,
if it were possible to identify the genetic factor(s) responsible for bleomycin sensi-
tivity, easier tests could be constructed to assess the same outcome. One such pos-
sibility is to identify the gene polymorphisms that affect the test outcome.
In this thesis work, we studied the effect of some XME (GSTM1, GSTT1, NAT2,
and BLHX) and DNA repair genes (XRCC1 and XRCC3) on the test outcome. These
genes are possibly involved in the bleomycin metabolism or the repair of bleomy-
cin-induced DNA lesions. This issue has not been previously explored.
It has been hypothesized that the genetic polymorphism of bleomycin hydro-
lase may account, at least partially, for the observed interindividual variation in ble-
omycin sensitivity (Caporaso, 1999). Also thought to be important in bleomycin
metabolism are GSTs and NAT2. Our results suggest that the BLHX normal geno-
type, especially combined with cigarette smoking, may contribute to a higher bleo-
mycin-induced break frequency.
The interpretation of the results is not straighforward, since exact data on the
BLHX genotype/phenotype correlation are not available. Although the variant allele
seems to be more efficient in inactivating the bleomycin in cell cultures, the differ-
ence is quite small. Bleomycin is a DNA-intercalating chemical, and it can be re-
moved from the DNA only if BLHX can effectively bind to the DNA (Koldamova et
al., 1998 and Lefterov et al., 1998). Because DNA binding is required for effective
inactivation of bleomycin by BLHX, the variant allele may increase enzyme activity
by allowing a more efficient DNA binding than the normal allele.
We found a probable interaction between cigarette smoking and BLHX geno-
type. The difference in b/c between normal and variant allele carriers was higher in
smokers than non-smokers. It may be possible that some constituents of cigarette
smoke increase the expression of BLHX in smokers, although this has not been shown.
While the BLHX genotype had only a slight effect on bleomycin sensitivity, the
XRCC1 codon 280 polymorphism exhibited a more profound effect. Carriers of XRCC1
280Gln variant allele displayed a higher b/c frequency than subjects homozygous for
the normal allele. If the cut-off point of 0.8 and 1.0 b/c are considered for sensitive
and hypersensitive individuals, the XRCC1 codon 280 polymorphism seems to have
a significant effect in predetermining whether the individual is sensitive.
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Bleomycin-induced damage is not repairable with BER without the glycosylase
and endonuclease activity. If the protein produced by the XRCC1 280Gln allele binds
to the DNA more efficiently than the protein produced by the normal allele, it could
prevent the efficient binding of glycosylase and endonuclease to the damaged site,
and slow down the repair process on bleomycin-induced lesions.
These results suggest that XRCC1 codon 280 polymorphisms may demonstrate
a major gene effect on the bleomycin sensitivity assay. On the basis of these results
cigarette smoking and polymorphisms in other genes, such as BLHX, seem also to
have a modulating role. The XRCC1 codon 280 polymorphism has rarely been stud-
ied in molecular epidemiology settings where DNA repair gene genotypes have been
determined. This is probably due to the low frequency of the variant allele. Our
results warrant further studies of this polymorphism, because even heterozygocity
for the variant allele seems to have profound effects on the level of bleomycin-in-
duced chromosome damage.
Our results disagree with those from a larger study conducted in another ethnic
(USA) group (Wang et al., 2003), which reports a nonsignificant association of XRCC1
codon 194 variant allele and codon 399 normal allele with a decreased number of
chromatid breaks. In our study, the XRCC1 194Trp variant allele was very rare, and
no homozygous carriers of this allele were found; this might explain why we did
not observe any effect for that particular polymorphism. Unfortunately, Wang et al.
did not analyze XRCC1 codon 280 polymorphism, and therefore no consensus can
be drawn from these bleomycin sensitivity studies. Clearly, a larger study simulta-
neously addressing all the relevant polymorphisms is needed.
The drawback of the bleomycin sensitivity assay has been the lack of knowl-
edge about its biological significance. The present results suggest that both metab-
olism of bleomycin and DNA repair capacity may alter the individual response to
bleomycin treatment. DNA repair genotypes seemed to be the predominant factors
affecting the test outcome.
Bleomycin sensitivity assay may now be used for cancer risk assessment with a
greater certainty, because on the basis of these results it appears to measure the
individual capacity of base excision repair. In the future, the mechanistic understanding
of the mutagen sensitivity trait would allow a better characterization of environmen-
tal cancer risks. In addition, the identification of a set of genes (in addition to XRCC1)
that provide the same information as the bleomycin sensitivity phenotype may be a
significant methodological improvement in identifying mutagen sensitive individu-
als, because genotype analysis is less laborous to perform than the current bleomy-
cin sensitivity assay based on cell culture and more or less subjective microscopic
analysis.
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4.2 Genotypes of metabolic and DNA repair genes and
cytogenetic damage
Direct DSBs, which can induce both SCEs and CAs, are probably rare events in normal
healthy cells. It has been estimated that about 50 DSBs are endogenously formed,
mainly from single-strand lesions, during every S-phase of the cell cycle (Vilenchik
et al., 2003), and these DSBs seem to be very effectively repaired. However, CAs are
present in certain amounts in peripheral blood leukocytes of healthy individuals,
and a few SCEs seem to be found in almost all cells. One possible mechanism for
their formation in healthy individuals in the absence of direct DSBs is enzymatic
induction from SSBs (Vilenchik et al., 2003). Alternatively, environmental exposure
to genotoxins (DNA adducts) may induce DSBs during the S-phase of the cell cycle
and chromosomal damage.
The people examined in the present study were mostly city dwellers, who were
likely to have been exposed to urban air pollution. Thus, in addition to possible
smoking, they probably had had some exposure to PAHs and other genotoxins in
the air, which may contribute to the observed level of chromosomal damage. Fur-
thermore, the human diet usually also contains a multitude of genotoxins, e.g., het-
erocyclic amines formed from amino acids by heating. In fact, for all practical pur-
poses, it is impossible to acquire a cohort, which has not been exposed to any geno-
toxins. Therefore, the current study does not actually assess how the polymorphisms
affect the baseline frequency of chromosomal damage, but rather how they modu-
late the extent of damage in minimally exposed individuals.
Our results indicate that neither the polymorphisms in the studied XME genes,
with a possible exception of GSTT1, nor in the DNA repair genes significantly affect
the frequency of SCEs in healthy Caucasians. Furthermore, the present study did
not indicate any connection between smoking and the XRCC1 codon 399 genotype
in determining the frequency of SCEs, in contrast to previous findings (Duell et al.,
2000 and Lei et al., 2002). One possible explanation for the divergence was the dif-
ference in sex distribution and smoking habits between our study population and
earlier studies.
The XRCC1, GSTT1, and NAT2 polymorphisms seem to affect the level of chro-
mosome breaks in cultured lymphocytes. The association of the GSTT1 null geno-
type and NAT2 slow acetylator genotypes with the elevated levels of chromosome
breaks is probably due to the diminished capacity of inactivation metabolism in the
cells.
Among XRCC3 Thr/Met heterozygotes, the frequency of chromatid breaks was
elevated in smokers but chromosome breaks were decreased in nonsmokers. These
findings appear difficult to explain at present, although XRCC3 might be present in
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trimeric complex of XRCC3, RAD51C and RAD51 (Liu et al., 2002), and show over-
dominant behavior. Overdominance is a state in which the heterozygote has greater
phenotype value and perhaps is more (or less) fit than the homozygous state for
either of the alleles that it comprises. Overdominance is best documented for tet-
rameric proteins, like haemoglobin and alcohol dehydrogenase (Hall et al., 1987),
but there is no reason why it could not explain phenotypic effects observed in tri-
meric protein complexes, like XRCC3-RAD51C-RAD51, also.
Our findings indicate that the XRCC1 codon 280 variant allele is associated with
an increased capacity to repair DNA strand breaks. The XRCC1 codon 280 is locat-
ed near the sequences that mediate the protein-protein interactions with poly(ADB-
ribose) polymerase (PARP) and DNA polymerase beta (Thompson, 2000). The 280Gln
variant allele may encode a twisted protein. This protein may have an increased or
decreased affinity to other proteins (PARP) or an altered DNA repair capacity (better
binding to DNA).
Our results also suggest that the link between chromosome breaks and predis-
position to cancer (Hagmar et al., 1998, Liou et al., 1999 and Bonassi et al., 2000)
may be in the polymorphic XME and DNA repair genes; they seem to raise the level
of cytogenetic damage, and have been associated, e.g., with cancers of the head
and neck (Sturgis et al., 1999), lungs (Henning, et al., 2000), and the larynx (Stucker
et al., 2002).
The current study extends our understanding about the inherited differences in
the xenobiotic metabolism and DNA repair. Whether determination of DNA repair
gene genotypes should be routinely incorporated into biomonitoring studies that
are based on CA tests, needs to be further studied. It might also be worthwhile to
include genotyping into studies of CAs and individual cancer risk.
4.3 DNA repair gene polymorphisms and the risk of up-
per aerodigestive tract cancers
Only two previous studies have investigated the role of XRCC2 polymorphisms in
cancer proneness (Kuschel et al., 2002; Rafii et al., 2002). In both studies the rare
XRCC2 188 His allele was linked to an elevated risk of sporadic breast cancer. The
results are consistent with our findings.
The XRCC2 188 His allele seems to have an effect on cell survival after treatment
with cross-linking reagents, such as mitomycin C (Rafii et al., 2002). Although this
effect appears to be small in general, no major biological defects can be expected
for low-penetrance genes. However, it may explain the slight but significant increase
in cancer risk.
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In the current study, the XRCC2 Arg188His polymorphism affected the risk of
pharyngeal cancers but not the risk of supraglottic cancers. Both cancers share the
same, very high risk linked to alcohol and tobacco consumption (Pèquignot et al.,
1988). Therefore, it is difficult to understand why the elevated cancer risk should be
limited only to supraglottic cancers.
There are at least two plausible explanations for the observation. In smokers,
higher levels of aromatic DNA adducts have been characterized in the pharynx than
in the larynx (Pabiszczak et al., 2001). Higher levels of bulky DNA adducts might
lead to higher levels of DNA double-strand breaks. This might explain why the ef-
fect of XRCC2 is limited to pharyngeal cancers. It is also possible that the type of the
DNA adducts differs between anatomical sites.
In contrast to an earlier report (Shen et al., 2002), we found that the XRCC3 241Met
allele is linked to a decreased risk of cancer. The allele frequencies of XRCC3 and
several other genes that were previously investigated using the same population
agreed well with the literature. However, we cannot totally exclude bias in the se-
lection of the controls.
The present results provide some evidence to support the idea that polymor-
phisms in the DNA repair genes that are involved in recombinatorial repair may
modulate susceptibility to the cancers of the upper aerodigestive tract.
4.4 Styrene-exposed lamination workers
In contrast to previous studies (Somorovská et al., 1999; Artuso et al., 1995), we did
not observe any effect of styrene exposure on CA frequencies. The SSB levels were
significantly lower among the exposed workers when compared with the controls,
and their level correlated inversely with the parameters reflecting external and inter-
nal exposure. This is in striking contrast to several previous studies (Vodic˘ka et al.,
1995; Somorovská et al., 1999; Brenner et al., 1991; Walles et al., 1993; Vodic˘ka et al.,
1999), where an exposure-related increase in the frequency of SSBs was found, and
where the frequency of SSBs correlated significantly with the frequency of O6-sty-
rene-guanine DNA adducts (Vodic˘ka et al., 1995) and the frequency of CAs (So-
morovská et al., 1999).
These discrepancies may be due to the differences between the populations stud-
ied. In the previous studies, styrene-exposed lamination workers had been regular-
ly exposed for more than 14 years on average, while the present workers were
exposed for four years on average, the majority of these had been employed in a
plastics plant for 1–2 years. The duration of exposure and the cumulative exposure
to styrene (and, presumably, to any chemical) may lead to a shift in the equilibrium
between an induction and inhibition of biotransformation and repair enzymes.
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Adaptation processes, as well as differences between long-term and short-term ex-
posures to potentially carcinogenic chemicals, have to be properly addressed in future
studies, so we can properly evaluate the genotoxic/carcinogenic risk of these xeno-
biotics.
In the present study, we employed two tests for the determination of DNA re-
pair capacity in humans. Irradiation-specific DNA repair capacity, attributable to BER,
was found to decrease moderately with age. It has previously been reported that
the DNA repair capacity correlates negatively with the number of cells with gaps,
and thus indicates a protective effect of DNA repair toward chromosome damage
(Knudsen et al., 1999). As DNA repair capacity seemed to increase with styrene
exposure in our study, it is possible that the DNA repair machinery participating in
the excision of the lesions from DNA had been effectively activated. DNA repair
capacity (both irradiation- and oxidation-specific) correlated significantly with the
concentration of styrene either in the air or blood, while the frequency of single-
strand breaks correlated with these parameters inversely. Important questions about
the true induction of DNA repair capacity, existence of a treshold in this induction,
and the situation in the long-term exposure (exhaustion related to increasing index
of cumulative exposure) remains to be studied.
In our study, the XRCC1 codon 399 variant allele was linked to an increased
number of SSBs and a decreased irradiation-specific DNA repair capacity, notice-
able particularly in the non-exposed group. Thus, our results add evidence to the
above observations that the XRCC1 codon 399 polymorphism affects the efficiency
of BER in human cells (Lunn et al., 1999; Abdel-Rahmann et al., 2002).
Interestingly, the frequency of SSBs, abasic sites, and 8-oxoguanosines were also
associated with the XPC polymorphism, involved in NER. It has been reported that
DNA repair capacity for the removal of UV photoproducts was the lowest in people
bearing homozygous XPC variant allele genotypes (Qiao et al., 2002). It is possible
that the DNA damage in styrene-exposed individuals is, at least partially, repaired
via NER. However, as the effect of the XPC polymorphism was not restricted to the
styrene-exposed workers, the association could be attributed to styrene exposure
or to other environmental/lifestyle factors.
In conclusion, the observed genotoxic effects in styrene-exposed workers prob-
ably depend on the extent of exposure, duration of exposure (Vodicka et al., 2002),
and individual susceptibility (complex combination of various XME and DNA repair
gene polymorphisms), as well as adaptational processes.
4.5 Limitations and future perspectives
The recent completion of a draft sequence of the human genome has dramatically
increased the number of known human polymorphisms. Availability of genomic
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sequence also enables computational identification of previously unknown poly-
morphisms. At the time the laboratory work for this study was started (and complet-
ed), the draft sequence of the human genome was not yet available, and the poly-
morphisms in the DNA repair genes were mined from published articles. Today, a
more comprehensive study of phenotypic consequences of the polymorphisms in
human DNA repair genes would be accomplished, if polymorphisms situated in the
promoter regions, introns and intron/exon borders were to be included. Such stud-
ies would also require large study populations.
Small sample size is the main limitation in current studies, and including more
polymorphisms would make this even more pronounced. The diseases and expo-
sures studied in this work are rare in Finland, and recruitment of larger study pop-
ulations could be challenging. For example, cytogenetic analyses are laborous to
perform, and it easily takes a whole day to score CAs for one individual only. Thus,
recruitment of study populations large enough for very powerful studies could take
years. Fortunately, CAs have already been scored for a number of people in cytoge-
netic laboratories in Finland and around Europe, but the availability of genetic material
for genotyping could limit the usability of this data.
In the current study, PCR-RFLP-based methods were used for genotyping the
individuals. This method is thought to be quite reliable, because it combines the
specificity of PCR with the specificity of the enzymatic DNA restriction reaction.
Unfortunately, the method is laborous, and not very fast to perform. Therefore, the
genotyping methods developed in this study were carefully optimized: In order to
speed up the analyses, the PCR programs were modified by removing the first de-
naturing step and the last elongation step. In addition, primers were optimized so
that both the annealing and elongation steps could be performed at the same tem-
perature. The amount of work was minimized by developing multiplex PCR reac-
tions. These improvements made genotyping much faster. With the current proto-
cols, genotypes of XRCC1 and XRCC3 can be determined from about 400 individ-
uals in a day. With robotics this could be speeded up even more, although even
faster and more easily automatized methods, such as PCR combined with denatur-
ing high performance liquid chromatography (HPLC), could be used.
The statistical methods used in this study were selected on the basis that they are
widely used standard methods. Multiple linear and Poisson regression are used, when
the dependent variable is either normally (SCEs) or Poisson distributed (CAs). Lo-
gistic regression is usually used, when the effect of a genotype in combination with
environment on the binomial disease outcome is analyzed. It would also be possi-
ble to use linkage disequilibrium (LD) in such cases, but construction of the disease
model, especially when many environmental factors are analyzed, could be tricky.
There are also non-parametric alternatives to most of the mentioned statistical meth-
ods.
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This study furthers current knowledge about the possible cellular mechanisms
involved in the formation of DNA and cytogenetic damage. The studied DNA repair
genes seem to influence the level of cytogenetic damage, and they might also ex-
plain the observed link between chromosomal aberrations and increased cancer risk.
Keeping in mind the small sample size of this study, it is possible that some poten-
tial effects of the DNA repair gene polymorphisms on the studied endpoints have
been missed. Thus, current findings need to be verified in larger studies. This study
also leaves some important questions unanswered. It might be interesting to see
whether DNA repair polymorphisms could actually explain the observed link be-
tween the high frequency of chromosome aberrations and elevated cancer risk.
Furthermore, the molecular mechanisms of chromosome aberration formation might
be studied in more detail in controlled in vitro studies.
In conclusion, it is obvious that an individual’s genotype for a number of detox-
ifying enzymes is likely to determine the individual’s response to carcinogenic com-
pounds. In the future, large homogeneous study populations are therefore needed
to allow proper analysis of the combined impact of various relevant genes for a
given exposure.
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The effects of polymorphisms in DNA repair genes XRCC1, XRCC2, XRCC3, XPC,
XPD, and XPG on mutagen sensitivity, frequency of CAs, risk of head and neck
cancers, and genotoxicity biomarkers in exposure to styrene were studied in four
Caucasian populations. The work included genotyping for XME (GSTM1, GSTT1,
and NAT2) and DNA repair gene polymorphisms as well as cytogenetic and statis-
tical analyses. The results showed that:
1. Mutagen (bleomycin) sensitivity was partly determined by bleomycin hydro-
lase genotype in smokers, and XRCC1 codon 280 polymorphism. The XRCC1
codon 280 polymorphism also affected the sensitivity classification of the sub-
jects.
2. The wildtype alleles of XRCC1 codons 194 and 280 were linked with an ele-
vated level of chromosome breaks in healthy, minimally exposed individuals.
The GSTT1 and NAT2 genotypes were also found to affect the number of
chromosome breaks in the healthy individuals. Heterozygosity for XRCC3
polymorphism was associated with elevated level of chromatid breaks.
3. SCE frequencies were not statistically significantly modulated by any of the
studied polymorphisms.
4. The XRCC2 188His allele was associated with an increased risk of pharyngeal
cancer. A reduced risk of supraglottic cancers was found for the carriers of the
XRCC3 variant allele.
5. The XRCC1 codon 399 polymorphism was associated with an elevated level
of SSBs in styrene exposed workers. The XRCC1 codon 399 polymorphisms
also affected the number of SSBs in cultured human lymphocytes after irradi-
ation treatment.
Effective repair of DNA lesions is essential for cell viability. As demonstated here,
the altered metabolism of xenobiotics and the reduced DNA repair capacity may
express themself as an increased number of DNA strand breaks and CAs or as a
higher cancer risk. It is also plausible that XME and DNA repair gene polymorphisms
modify the relationship between the frequency of CAs and the risk of cancer.
GENERAL CONCLUSIONS
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The reference to the source of the following text on page 13 was accidentally 
omitted. The following chapters should read as: 
 
CAs, as viewed through a microscope on a metaphase preparation, are end products 
of complex cellular systems. Metaphase chromosomes can be produced by 
colchicin (or its analogue Colcemid) arrest during cell division of cycling cells; 
CAs are normally scored from non-banded (“solid”), stained metaphase 
preparations of lymphocytes stimulated to divide by a mitogen. Radiation-induced 
damage can be observed as chromosome- or chromatid-type aberrations, depending 
on whether the cell resided in G0/G1 or G2 phase of the cell cycle, respectively, at 
the time of irradiation. (A slightly modified excerpt from Lindholm, 2000) 
  
According to the most cited theory, breakage-and-reunion, misrepair of illegitimate 
rejoining of break-ends produces structural aberrations between two different 
chromosomes (interchanges) or within one chromosome (intrachanges) (Savage, 
1975). In the case of an asymmetrical interchange, the centromeres of both 
chromosomes are located on the same piece, and an accompanying acentric 
fragment is present. This dicentric chromosome is easily recognizable after 
conventional staining. Reciprocal translocation involves mutual exchange of 
chromatin pieces, and only large rearrangements can be detected in solid stained 
preparations. If two breaks are located within one chromosome, one on each side of 
centromere, an easily observable ring chromosome can be produced. Pericentric 
inversion formed from the same lesion cannot usually be distinguished by solid 
staining. In cases where breaks remain dissociated, terminal or interstitial deletions 
are formed. The terminal deletions can be detected as acentric fragments, whereas 
interstitial deletions appear as either small double minutes or acentric rings. (A 
slightly modified excerpt from Lindholm, 2000) 
 
The radiation- or chemical-induced CAs can be classified as chromatid-type or 
chromosome-type aberrations (Savage, 1975). Deletions are seen as chromatid- and 
chromosome-type breaks (Figure -II), the former affecting one chromatid and the 
latter both sister chromatids at the same site. Dicentrics, ring chromosomes and 
double minutes are classified as chromosome-type aberrations, whereas chromatid-
type aberrations include symmetrical and asymmetrical exchanges within a 
chromosome (intrachanges) and between two or more chromosomes 
(interchanges). (A slightly modified excerpt from Lindholm, 2000) 
 
Lindholm, C. (2000) Stable chromosome aberrations in the reconstruction of 
radiation doses, doctoral dissertation, STUK A176. 
 
 
 
The following errors were found after printing: 
 
 
Page 6, lines 12-15 
 
The XRCC1 codon 280 variant allele was associated with elevated number of 
chromosome breaks induced by bleomycin in vitro (mutagen sensitivity), and with 
a higher frequency of chromosome breaks in peripheral blood lymphocytes of 
individuals with low exposure levels. 
 
Should be: 
 
The XRCC1 codon 280 variant allele was associated with elevated number of 
chromosome breaks induced by bleomycin in vitro (mutagen sensitivity), and with 
a lower frequency of chromosome breaks in peripheral blood lymphocytes of 
individuals with low exposure levels. 
 
 
Page 52, paragraph 3, lines 5-6: 
 
Similarly, the NAT2 slow acetylator genotype decreased the frequency of 
chromosome breaks in non-smokers. 
 
Should be: 
 
Similarly, the NAT2 slow acetylator genotype increased the frequency of 
chromosome breaks in non-smokers. 
 
 
Page 59, paragraph 2, lines 4-7: 
 
The 280Gln variant allele may encode a twisted protein. This protein may have an 
increased or decreased affinity to other proteins (PARP) or an altered DNA repair 
capacity (better binding to DNA). 
 
Should be: 
 
The 280His variant allele may encode a twisted protein. This protein may have an 
increased or decreased affinity to other proteins (PARP) or an altered DNA repair 
capacity (better binding to DNA). 
 
